<SEC-DOCUMENT>0000927066-20-000219.txt : 20201113
<SEC-HEADER>0000927066-20-000219.hdr.sgml : 20201113
<ACCEPTANCE-DATETIME>20201113161606
ACCESSION NUMBER:		0000927066-20-000219
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20201106
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201113
DATE AS OF CHANGE:		20201113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DAVITA INC.
		CENTRAL INDEX KEY:			0000927066
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				510354549
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14106
		FILM NUMBER:		201311684

	BUSINESS ADDRESS:	
		STREET 1:		2000 16TH STREET
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202
		BUSINESS PHONE:		310-536-2668

	MAIL ADDRESS:	
		STREET 1:		2000 16TH STREET
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAVITA HEALTHCARE PARTNERS INC.
		DATE OF NAME CHANGE:	20121107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAVITA INC
		DATE OF NAME CHANGE:	20001005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TOTAL RENAL CARE HOLDINGS INC
		DATE OF NAME CHANGE:	19950524
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>formresettlementderiva.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:57dc5175101f465981e534a153b3d94a,x:5d3fed1ae91c44e5bd2e80b25dfd43eb-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2019-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2019-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2019-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2019-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2019-01-31" xmlns:lea="http://fasb.org/dis/lea/2019-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2019-01-31" xmlns:guar="http://fasb.org/dis/guar/2019-01-31" xmlns:ru="http://fasb.org/dis/ru/2019-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2019-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2019-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2019-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2019-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:cce="http://fasb.org/dis/cce/2019-01-31" xmlns:inv="http://fasb.org/dis/inv/2019-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:srt-std="http://fasb.org/srt-std/2019-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2019-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2019-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2019-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2019-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2019-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2019-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2019-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:re="http://fasb.org/dis/re/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2019-01-31" xmlns:invco="http://fasb.org/dis/invco/2019-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2019-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2019-01-31" xmlns:currency-ent-dep="http://xbrl.sec.gov/currency-ent-dep/2019-01-31" xmlns:aro="http://fasb.org/dis/aro/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:srt-all="http://fasb.org/srt-all/2019-01-31" xmlns:codification-part="http://fasb.org/codification-part/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:sec-re="http://fasb.org/dis/sec-re/2019-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2019-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2019-01-31" xmlns:equity="http://fasb.org/dis/equity/2019-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:se="http://fasb.org/dis/se/2019-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2019-01-31" xmlns:edco="http://fasb.org/dis/edco/2019-01-31" xmlns:te="http://fasb.org/dis/te/2019-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2019-01-31" xmlns:hco="http://fasb.org/dis/hco/2019-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:dr="http://fasb.org/dis/dr/2019-01-31" xmlns:ero="http://fasb.org/dis/ero/2019-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2019-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2019-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2019-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2019-01-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2019-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2019-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2019-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2019-01-31" xmlns:soi="http://fasb.org/stm/soi/2019-01-31" xmlns:diha="http://fasb.org/dis/diha/2019-01-31" xmlns:debt="http://fasb.org/dis/debt/2019-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2019-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2019-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2019-01-31" xmlns:rd="http://fasb.org/dis/rd/2019-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2019-01-31" xmlns:eui="http://fasb.org/dis/eui/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ap="http://fasb.org/dis/ap/2019-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2019-01-31" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2019-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dva="http://www.davita.com/20201106" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2019-01-31" xmlns:sr="http://fasb.org/dis/sr/2019-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2019-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2019-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2019-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2019-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2019-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2019-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2019-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2019-01-31" xmlns:oi="http://fasb.org/dis/oi/2019-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2019-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2019-01-31" xmlns:cc="http://fasb.org/dis/cc/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2019-01-31" xmlns:disops="http://fasb.org/dis/disops/2019-01-31" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:cn-part="http://fasb.org/cn-part/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2019-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2019-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2019-01-31" xmlns:ts="http://fasb.org/dis/ts/2019-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2019-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2019-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:ni="http://fasb.org/dis/ni/2019-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2019-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2019-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2019-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2019-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2019-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2019-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2019-01-31" xmlns:ir="http://fasb.org/dis/ir/2019-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2019-01-31" xmlns:foct="http://fasb.org/dis/foct/2019-01-31" xmlns:soc="http://fasb.org/stm/soc/2019-01-31" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2019-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2019-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2019-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:con="http://fasb.org/dis/con/2019-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2019-01-31" xmlns:eps="http://fasb.org/dis/eps/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2019-01-31" xmlns:pay="http://fasb.org/dis/pay/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:tin-part="http://fasb.org/tin-part/2019-01-31" xmlns:acec="http://fasb.org/dis/acec/2019-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2019-01-31" xmlns:nt="http://fasb.org/dis/nt/2019-01-31" xmlns:spc="http://fasb.org/stm/spc/2019-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2019-01-31" xmlns:ides="http://fasb.org/dis/ides/2019-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2019-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:regop="http://fasb.org/dis/regop/2019-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2019-01-31" xmlns:com="http://fasb.org/stm/com/2019-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2019-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2019-01-31" xmlns:exch-ent-dep="http://xbrl.sec.gov/exch-ent-dep/2019-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ei="http://fasb.org/dis/ei/2019-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="D2020Q4Settlement" name="dei:AmendmentFlag" id="Fact-BA41EB73F33DA7178E7AAF64EB617CAE-wk-Fact-BA41EB73F33DA7178E7AAF64EB617CAE" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="D2020Q4Settlement" name="dei:EntityCentralIndexKey" id="Fact-41A3CD831491C17AF572AF64EB5F9A0F-wk-Fact-41A3CD831491C17AF572AF64EB5F9A0F">0000927066</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="dva-20201106.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="D2020Q4Settlement">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-11-06</xbrli:startDate>
			<xbrli:endDate>2020-11-06</xbrli:endDate>
		</xbrli:period>
	</xbrli:context></ix:resources></ix:header></div><div><a id="s462D970F39CFD2212659AF64EB8D2C24"></a></div><div style="line-height:120%;-sec-extract:summary;"><hr></hr></div><div style="line-height:100%;padding-top:1px;text-align:center;font-size:4pt;"><span style="font-family:inherit;font-size:4pt;">&#160;</span></div><div style="line-height:120%;text-align:center;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES </span></div><div style="line-height:120%;text-align:center;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">Washington, D.C. 20549 </span></div><div style="line-height:120%;text-align:left;-sec-extract:summary;"><hr></hr></div><div style="line-height:120%;text-align:center;font-size:18pt;"><span style="font-family:inherit;font-size:7.5pt;">&#160;</span><span style="font-family:inherit;font-size:18pt;font-weight:bold;">Form </span><span><ix:nonNumeric id="d52252e97-wk-Fact-5E0B1C6A6861392752FBAF64EB680275" name="dei:DocumentType" contextRef="D2020Q4Settlement"><span style="font-size:18pt;font-weight:bold;">8-K</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:7.5pt;">&#160;</span></div><div style="line-height:120%;-sec-extract:summary;"><hr></hr></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:7.5pt;">&#160;</span><span style="font-family:inherit;font-size:12pt;font-weight:bold;">CURRENT REPORT </span></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:7.5pt;">&#160;</span><span style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant to Section 13 or 15(d) of the </span></div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">Securities Exchange Act of 1934 </span></div><div style="line-height:120%;text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">&#160;</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Date of Report (date of earliest event reported): </span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d52252e124-wk-Fact-AB2B5AF73D8902B67BE8AF64EB6722C9" name="dei:DocumentPeriodEndDate" contextRef="D2020Q4Settlement" format="ixt:datemonthdayyearen">November 6, 2020</ix:nonNumeric></span></span></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">&#160;</span></div><div style="line-height:100%;text-align:center;padding-left:288px;-sec-extract:summary;"><hr></hr></div><div style="line-height:120%;text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">&#160;</span></div><div style="line-height:120%;text-align:center;font-size:24pt;"><span><ix:nonNumeric id="d52252e137-wk-Fact-AE5A41C0039D9BACD02CAF64EB63CFE1" name="dei:EntityRegistrantName" contextRef="D2020Q4Settlement"><span style="font-size:24pt;font-weight:bold;">DAVITA INC.</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:24pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">(Exact name of registrant as specified in its charter) </span></div><div style="line-height:120%;text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">&#160;</span><hr></hr></div><div style="line-height:120%;text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">&#160;</span></div><div style="line-height:120%;text-align:center;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d52252e166-wk-Fact-176130BBF864BF4514F5AF64EB6F2870" name="dei:EntityIncorporationStateCountryCode" contextRef="D2020Q4Settlement">DE</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d52252e171-wk-Fact-FA4C98DD8A69294E29D6AF64EB60706B" name="dei:EntityFileNumber" contextRef="D2020Q4Settlement">1-14106</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d52252e176-wk-Fact-B0E7B8617CCAC724532CAF64EB6D728B" name="dei:EntityTaxIdentificationNumber" contextRef="D2020Q4Settlement">51-0354549</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">(State or other jurisdiction</span></div><div style="padding-bottom:1px;text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">of incorporation)</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">(Commission File Number)</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">(IRS Employer</span></div><div style="padding-bottom:1px;text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Identification No.)</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:7.5pt;">&#160;</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:18.007662835249043%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:44%;"></td><td style="width:22%;"></td><td style="width:34%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d52252e216-wk-Fact-7118C4961F92B2591DABAF64EB6D9FE4" name="dei:EntityAddressAddressLine1" contextRef="D2020Q4Settlement">2000 16th Street</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d52252e232-wk-Fact-E20449539E45A7F1D89BAF64EB630386" name="dei:EntityAddressCityOrTown" contextRef="D2020Q4Settlement">Denver,</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d52252e237-wk-Fact-DC1AF8001993382D07C7AF64EB5EF4FE" name="dei:EntityAddressStateOrProvince" contextRef="D2020Q4Settlement">CO</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d52252e242-wk-Fact-98CDAC3013CA9592B732AF64EB619F7B" name="dei:EntityAddressPostalZipCode" contextRef="D2020Q4Settlement">80202</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;"> (Address of principal executive offices including Zip Code) </span></div><div style="line-height:120%;text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">&#160;</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">(</span><span><ix:nonNumeric id="d52252e254-wk-Fact-6D530121D2ADA6B76AB5AF64EB5F4BCF" name="dei:CityAreaCode" contextRef="D2020Q4Settlement"><span style="font-weight:bold;">720</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;">) </span><span><ix:nonNumeric id="d52252e259-wk-Fact-DA2BC3ED2C467412CD7AAF64EB6AC5F3" name="dei:LocalPhoneNumber" contextRef="D2020Q4Settlement"><span style="font-weight:bold;">631-2100 </span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;"> (Registrant&#8217;s telephone number, including area code) </span></div><div style="line-height:120%;text-align:left;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;">&#160;</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Not applicable </span></div><div style="line-height:120%;text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">(Former name or former address, if changed since last report) </span></div><div style="line-height:120%;text-align:left;-sec-extract:summary;"><hr></hr></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </span></div><div style="line-height:120%;text-align:left;font-size:7pt;"><span style="font-family:inherit;font-size:7pt;">&#160;</span></div><div style="line-height:120%;font-size:10pt;"><span><ix:nonNumeric id="d52252e285-wk-Fact-F273D264E6B0D8CF4FFAAF64EB616C33" name="dei:WrittenCommunications" contextRef="D2020Q4Settlement" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425) </span></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:7pt;"><span style="font-family:inherit;font-size:7pt;">&#160;</span></div><div style="line-height:120%;font-size:10pt;"><span><ix:nonNumeric id="d52252e296-wk-Fact-60FB6850298D753F2E04AF64EB6C459B" name="dei:SolicitingMaterial" contextRef="D2020Q4Settlement" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:7pt;"><span style="font-family:inherit;font-size:7pt;">&#160;</span></div><div style="line-height:120%;padding-top:0px;font-size:10pt;"><span><ix:nonNumeric id="d52252e306-wk-Fact-D58EBE4872B6E72CB504AF64EB65C0BA" name="dei:PreCommencementTenderOffer" contextRef="D2020Q4Settlement" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:7pt;"><span style="font-family:inherit;font-size:7pt;">&#160;</span></div><div style="line-height:120%;font-size:10pt;"><span><ix:nonNumeric id="d52252e316-wk-Fact-A5E8F6AA722C542227FAAF64EB6688F3" name="dei:PreCommencementIssuerTenderOffer" contextRef="D2020Q4Settlement" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div style="line-height:120%;padding-top:8px;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:29%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td><td style="width:45%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Title of each class:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Trading symbol(s):</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Name of each exchange on which registered:</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d52252e367-wk-Fact-AC75842858E7125CE313AF64EB6A9C86" name="dei:Security12bTitle" contextRef="D2020Q4Settlement">Common Stock, $0.001 par value</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d52252e377-wk-Fact-358F54F98F29E8C46493AF64EB695A45" name="dei:TradingSymbol" contextRef="D2020Q4Settlement">DVA</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d52252e387-wk-Fact-932A0BD7D4D0099DB33CAF64EB6BAB28" name="dei:SecurityExchangeName" contextRef="D2020Q4Settlement" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="line-height:120%;padding-top:4px;font-size:10pt;"><span><ix:nonNumeric id="d52252e393-wk-Fact-491764557AC0563585C4AF64EB6E3022" name="dei:EntityEmergingGrowthCompany" contextRef="D2020Q4Settlement" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">Emerging growth company </span></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     &#9744;</span></div><div style="line-height:120%;-sec-extract:summary;"><hr></hr></div><div><br/></div><div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;-sec-extract:summary;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s9C6091B96E160AEC5640AF64ECACD9DF"></a></div><div><br/></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;padding-bottom:12px;-sec-extract:summary;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 8.01.</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Events.</span></div></td></tr></table><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As previously disclosed in its Quarterly Report on Form 10-Q for the Quarter ended June 30, 2020 (&#8220;Form 10-Q&#8221;), DaVita Inc. (the &#8220;Company&#8221;) reached an agreement in principle in July 2020 to resolve </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">In re DaVita Inc. Stockholder Derivative Litigation</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">1:17-cv-00152-MPT</span><span style="font-family:inherit;font-size:10pt;">, a stockholder derivative action pending in the U.S. District Court for the District of Delaware (the &#8220;Court&#8221;) on behalf of the Company against certain of its officers and directors (the &#8220;Settlement&#8221;). In the Form 10-Q, the Company also reported that the Settlement was subject to, among other things, approval by the Court.&#160;</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On November 6, 2020, the Court granted preliminary approval of the Settlement.  In accordance with the Court&#8217;s Order Preliminarily Approving Derivative Settlement and Providing for Notice,  the Company is hereby providing, as Exhibits 99.1 and 99.2 to this Current Report on Form&#160;8-K, the Stipulation of Settlement and Notice of Proposed Derivative Settlement (the &#8220;Notice&#8221;). Pursuant to the Stipulation of Settlement, the Company has agreed to certain governance policies and for the Company&#8217;s insurer to pay to plaintiff&#8217;s counsel certain legal fees and expenses.</span></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">This Current Report on Form 8-K, the Stipulation of Settlement and the Notice are also available on the Company&#8217;s website at </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">https://investors.davita.com/</span><span style="font-family:inherit;font-size:10pt;">. This website address is included for reference only. The information contained on the Company&#8217;s website is not incorporated by reference into this Current Report on Form 8-K. In accordance with the Stipulation of Settlement, a summary of the Notice is expected to be published in the national edition of </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Investor&#8217;s Business Daily</span><span style="font-family:inherit;font-size:10pt;"> as an additional form of notice to the Company&#8217;s stockholders.</span></div><div style="line-height:120%;padding-bottom:16px;padding-top:12px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Forward-Looking Statements</span></div><div style="line-height:120%;padding-bottom:16px;padding-top:12px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">This Current Report on Form 8-K contains forward-looking statements within the meaning of the federal securities laws. All such statements in this report, other than statements of historical fact, are forward-looking statements. Words such as "expect," "intend," "will," "plan," "anticipate," "believe," "continue," and similar expressions are intended to identify forward-looking statements.&#160;&#160;The Company bases its forward-looking statements on information available to it on the date of this report, and undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of changed circumstances, new information, future events or otherwise, except as may otherwise be required by law. Actual results and other events could differ materially from any forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things,&#160;the&#160;risk factors set forth in the Company&#8217;s reports on Form 10-K and Form 10-Q and the other risks and uncertainties&#160;discussed in&#160;any subsequent reports that the Company files with the Securities and Exchange Commission from time to time.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01. Financial Statements and Exhibits.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(d) Exhibits.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.61111111111111%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:15%;"></td><td style="width:85%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit</span></div><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex991-stipulationofset.htm"><span style="font-family:inherit;font-size:10pt;">99.1</span></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stipulation of Settlement, dated October 23, 2020.</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex992-noticeofproposed.htm"><span style="font-family:inherit;font-size:10pt;">99.2</span></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Notice of Proposed Derivative Settlement. </span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">104.0</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document  </span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sE099BBAE7CF2EA445077AF64ECCC5DB4"></a></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div><div style="line-height:120%;text-align:left;text-indent:33px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div><div style="line-height:120%;padding-left:9px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.61111111111111%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:45%;"></td><td style="width:5%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DAVITA INC.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Date: November 13, 2020</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">By:</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">/s/ Kathleen A. Waters</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Kathleen A. Waters</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Chief Legal Officer</span></div></td></tr></table></div></div><div style="line-height:120%;padding-left:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991-stipulationofset.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s6D44F8C6E8889B8A6F65B910796BE262"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT 99.1</font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">IN THE UNITED STATES DISTRICT COURT</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">FOR THE DISTRICT OF DELAWARE</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:50%;"></td><td style="width:4%;"></td><td style="width:46%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In re DaVITA, INC. STOCKHOLDER DERIVATIVE LITIGATION</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="padding-top:16px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Document Relates To:</font></div><div style="padding-top:16px;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ALL ACTIONS.</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;padding-left:18px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="padding-bottom:16px;padding-left:18px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Case No. 1:17-cv-00152-MPT</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">STIPULATION OF SETTLEMENT</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Stipulation of Settlement, dated October 23, 2020 (&#8220;Stipulation&#8221; or &#8220;Settlement&#8221;), is made and entered into by and among the following parties, and by and through their respective counsel:  (i) Lead Plaintiff City of Warren Police and Fire Retirement System (the &#8220;City of Warren P &amp; F&#8221;), in the action captioned </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">In re DaVita, Inc. Stockholder Derivative Litigation</font><font style="font-family:inherit;font-size:12pt;">, Civil Action No. 1:17-cv-00152-MPT (the &#8220;Action&#8221;) (on behalf of itself and derivatively on behalf of DaVita, Inc. (&#8220;DaVita&#8221; or the &#8220;Company&#8221;)); (ii)&#160;Defendants Kent J. Thiry, Pamela M. Arway, Charles G. Berg, Carol Anthony &#8220;John&#8221; Davidson, Barbara J. Desoer, Paul J. Diaz, Peter T. Grauer, John M. Nehra, William L. Roper, Roger J. Valine, Robert J. Margolis, Garry E. Menzel, and James K. Hilger (together, &#8220;Settling Defendants&#8221;); and (iii) Nominal Party DaVita (together, the &#8220;Settling Parties&#8221;).  The Stipulation is intended by the Settling Parties to fully, finally and forever resolve, discharge and settle the Released Claims (as defined below) upon Court approval and subject to the terms and conditions hereof.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">I.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">BRIEF OVERVIEW OF THE ACTION</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">A.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Commencement and Consolidation of the Action</font></div></td></tr></table><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Beginning on February 10, 2017, Plaintiffs City of Warren Police and Fire Retirement System and Charles Blackburn filed shareholder derivative actions on behalf of DaVita for violations of &#167;14(a) of the Securities Exchange Act of 1934, breach of fiduciary duty and other relief in the United States District Court for the District of Delaware.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On August 15, 2017, the Court, the Honorable Chief Magistrate Judge Mary Pat Thynge presiding, consolidated the actions.  On the same date, the Court appointed City of Warren Police and Fire Retirement System as Lead Plaintiff, Robbins Geller Rudman &amp; Dowd LLP was appointed Lead Counsel, and Andrews &amp; Springer LLC as Delaware counsel.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On September 29, 2017, Lead Plaintiff filed the operative Consolidated Complaint.  The Consolidated Complaint asserts claims against Defendants for breaches of fiduciary duties, unjust enrichment, corporate waste and violations of &#167;14(a) of the Securities Exchange Act of 1934.  Verified Consolidated Shareholder Derivative Complaint filed on September&#160;29, 2017 ( D.I. 13) at &#182;1.  It further alleges that a pre-suit demand upon the DaVita Board is unnecessary because a majority of the directors: (i) consciously implemented a system designed to game the Affordable Care Act (&#8220;ACA&#8221;) by improperly steering end stage renal disease (&#8220;ESRD&#8221;) patients to private insurance in order to boost profits and hide their scheme from shareholders, both of which are not protected conduct under the business judgment rule; and (ii) face a substantial likelihood of liability for consciously allowing these practices to persist.  </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">Id.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">B.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Defendants&#8217; Motion to Stay and Motion to Dismiss</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On December 18, 2017, Defendants moved to dismiss the Consolidated Complaint for failure to sufficiently plead demand futility and separately moved to stay the consolidated actions pending the outcome of the motions to dismiss the related Securities Class Action </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">pending in the United States District Court for the District of Colorado.  D.I. 20-25; </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">see</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">also</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">Peace Officers&#8217; Annuity and Benefit Fund of Ga. v. DaVita Inc. et al.</font><font style="font-family:inherit;font-size:12pt;">, No. 1:17-cv-00304-WJM-MJW (D. Co.).</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Lead Plaintiff opposed each motion on March 9, 2018.  D.I. 27.  Lead Plaintiff additionally moved to strike materials attached to and discussed in Defendants&#8217; memorandum of law in support of the motion to dismiss.  D.I.&#8217;s 28-29.  Defendants filed a reply in support of their motion to dismiss on May 4, 2018.  D.I.&#8217;s 33-34.  Defendants also separately filed an opposition to Lead Plaintiff&#8217;s motion to strike.  On June 25, 2018, the Court granted the motion to stay, which continued through status conferences on November&#160;1, 2018 and January 7, 2019.  D.I.&#8217;s 37, 44.  On January 7, 2019, with no decision yet issued in the Securities Class Action, the Court ordered the parties to submit a joint proposed scheduling order, which the parties did on February 8, 2019.  D.I. 47.  The Court ordered the scheduling order into effect on February 28, 2019.  D.I. 48.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On April 25, 2019, this Court denied Defendants&#8217; motion to dismiss the derivative claims.  D.I. 50.  </font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On May 28, 2019, Defendants and DaVita answered the Consolidated Complaint (D.I. 51, 52), and on June 12, 2019, the parties made their initial disclosures under Federal Rule of Civil Procedure 26(a)(l).  </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">See</font><font style="font-family:inherit;font-size:12pt;">&#32;D.I.&#8217;s 53, 53-55.  On August 16, 2019, the Court entered an updated scheduling order setting a fact discovery cutoff of July 24, 2020, an expert discovery cutoff of October 30, 2020, and a trial date of October 4, 2021.  </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">See</font><font style="font-family:inherit;font-size:12pt;">&#32;D.I. 62.  In light of the impact of the COVID-19 pandemic and a ransom-ware attack on one of Defendants&#8217; discovery vendors, on May 12, 2020, the Court entered a further updated scheduling order setting the fact discovery cutoff of October 22, 2020, expert discovery </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">cutoff of February 9, 2021, and a trial date to be determined after a decision is rendered on the case dispositive motions.  </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">See</font><font style="font-family:inherit;font-size:12pt;">&#32;D.I. 76.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">C.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Discovery</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On July 26, 2019, the Court conducted a scheduling teleconference, and on August 16, 2019, issued a Scheduling Order establishing a pre-trial schedule.  D.I. 62.  Thereafter, the parties began to engage in an extensive discovery process.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">As discovery progressed, Lead Plaintiff served written discovery on Defendants and issued subpoenas to third-parties.  As of today, Defendants have produced and Lead Plaintiff has reviewed and analyzed over 800,000 pages of documents.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">D.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Settlement Negotiations</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In the fall of 2019, the parties agreed to participate in a private mediation before the Honorable Layn R. Phillips (&#8220;Judge Phillips&#8221;), United States District Judge (Ret.).  The parties then participated in an in-person mediation session before Judge Phillips on September&#160;25, 2019.  The September 2019 mediation was unsuccessful.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">While the parties pushed forward with the litigation and discovery, the Settling Parties continued to talk about resolution with the help of Judge Phillips.  After additional months of discovery, the Settling Parties engaged in a second mediation session with Judge Phillips on June 27, 2020.  While the Settling Parties did not reach an agreement to settle the Action at that session, the Settling Parties continued negotiations with the assistance of Judge Phillips in parallel with ongoing discovery.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Ultimately, these efforts culminated with the Settling Parties accepting a mediators&#8217; proposal on July 15, 2020.  The settlement terms include a $50 million payment to the </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Company on behalf of the Individual Defendants and the Company agreeing to adopt certain Corporate Governance Policies set forth in &#182;2.4 herein, subject to Court approval.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">E.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Approval of the Settlement by the DaVita Board</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On October 20, 2020, the DaVita Board, exercising its business judgment, unanimously approved the Settlement and each of its terms as providing a substantial benefit to the Company and, thus, being in the best interest of DaVita and its stockholders.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">II.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CLAIMS OF LEAD PLAINTIFF AND BENEFITS OF SETTLEMENT</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Lead Plaintiff and its counsel believe the claims asserted in the Action have merit.  However, Lead Plaintiff and its counsel recognize and acknowledge the expense and length of continued proceedings necessary to prosecute the Action against the Settling Defendants through trial and potential appeals.  Lead Plaintiff and its counsel also have taken into account the uncertain outcome and the risk of any litigation, especially in a complex action such as this one, as well as the difficulties and delays inherent in such litigation.  Lead Plaintiff and its counsel also are mindful of the inherent problems of proof of, and possible defenses to, the claims asserted in the Action.  Based on their evaluation, Lead Plaintiff and its counsel believe that the Settlement set forth in this Stipulation is in the best interests of DaVita and its stockholders.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">III.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">THE SETTLING DEFENDANTS&#8217; DENIALS OF WRONGDOING AND LIABILITY</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Settling Defendants have denied and continue to deny each and every one of the claims and contentions alleged by Plaintiffs in the Action.  Each of the Settling Defendants </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">expressly has denied and continues to deny any and all allegations of fault, wrongdoing, liability or damages whatsoever.  Settling Defendants expressly deny that Plaintiffs have asserted any valid claims as to any of them and expressly deny claims as to any of them arising out of, based upon or related to any of the conduct, statements, acts or omissions alleged, or that could have been alleged, in the Action.  Without limiting the foregoing, the Settling Defendants have denied and continue to deny, among other things, that they breached their fiduciary duties or any other duty owed to DaVita or its stockholders, or that Plaintiffs, DaVita, or its stockholders suffered any damage or were harmed as a result of any conduct alleged in the Action or otherwise.  The Settling Defendants have further asserted and continue to assert that at all relevant times, their conduct was proper and in compliance with all applicable provisions of law and believe the evidence developed to date supports their position that they acted in good faith and in a manner they reasonably believed to be in the best interests of DaVita and its stockholders and that the Action is without merit.  In addition, Settling Defendants maintain that they have meritorious defenses to all claims alleged in the Action and that DaVita&#8217;s existing corporate governance policies were not deficient.  </font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Nonetheless, the Settling Defendants also have taken into account the expense, uncertainty and risks inherent in any litigation, especially in a complex case like the Action.  Therefore, the Settling Defendants have determined that it is desirable and beneficial that the Action, and all of the Settling Parties&#8217; disputes related thereto, be fully and finally settled in the manner and upon the terms and conditions set forth in this Stipulation.  For the avoidance of doubt, Settling Defendants are entering into this Stipulation solely to eliminate the uncertainty, burden and expense of further protracted litigation.  Pursuant to the terms set forth below, this Stipulation (including all of the Exhibits hereto) shall in no event be construed as or deemed to be evidence of an admission or concession on the part of any of </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">6</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">the Settling Defendants with respect to any claim or any allegation of any fault, liability, wrongdoing, or damage whatsoever, or any infirmity in the defenses that Settling Defendants have, or could have, asserted.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">IV.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">TERMS OF STIPULATION AND AGREEMENT OF SETTLEMENT</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NOW, THEREFORE, IT IS HEREBY STIPULATED AND AGREED by and among the Lead Plaintiff (for itself and derivatively on behalf of DaVita), the Settling Defendants, and DaVita, by and through their respective undersigned attorneys and subject to the approval of the Court pursuant to Federal Rule of Civil Procedure 23.1(c) that in exchange for the consideration set forth below, the Action and Released Claims shall be fully, finally and forever compromised, settled, discharged, relinquished and released, and the Action shall be dismissed with prejudice as to the Settling Defendants, upon and subject to the following terms and conditions:</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Definitions</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">As used in this Stipulation the following terms have the meanings specified below:</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.1</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;Action&#8221; means, collectively, the consolidated shareholder derivative action pending in the United States District Court for the District of Delaware under the caption </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">In re DaVita, Inc. Stockholder Derivative Litigation</font><font style="font-family:inherit;font-size:12pt;">, Civil Action No. 1:17-cv-00152-MPT, pending for all purposes before the Honorable Chief Magistrate Judge Mary Pat Thynge.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.2</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;DaVita&#8221; means DaVita, Inc., including, but not limited to, its predecessors, successors, subsidiaries, affiliates, divisions, and assigns.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.3</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#32;&#8220;Court&#8221; means the United States District Court for the District of Delaware.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.4</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;Effective Date&#8221; means the first date by which all of the events and conditions specified in &#182;6.1 of this Stipulation have been met and have occurred.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.5</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#32;&#8220;Final&#8221; means the time when the Judgment has not been reversed, vacated, or modified in any way and is no longer subject to appellate review, either because of disposition on appeal and conclusion of the appellate process or because of passage, without action, of time for seeking appellate review.  More specifically, it is that situation when: (1)&#160;the time to file a motion to alter or amend the Judgment under Federal Rule of Civil Procedure 59(e) has passed without any such motion having been filed; (2) either no appeal has been filed and the time has passed for any notice of appeal to be timely filed in the Action; (3) an appeal has been filed and the court(s) of appeal has/have either affirmed the Judgment or dismissed that appeal and the time for any reconsideration or further appellate review has passed and the appellate court mandate(s) has/have issued; or (4) a higher court has granted further appellate review and that court has either affirmed the underlying Judgment or affirmed the court of appeal&#8217;s decision affirming the Judgment or dismissing the appeal.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.6</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;Final Approval Order&#8221; means the Order Approving Derivative Settlement and Order of Dismissal with Prejudice, substantially in the form attached as Exhibit B hereto.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.7</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;Judgment&#8221; means the judgment to be rendered by the Court in the Action upon its final approval of the Settlement, substantially in the form attached as Exhibit C hereto.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.8</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;Lead Plaintiff&#8221; means the City of Warren Police and Fire Retirement System.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.9</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;Lead Plaintiff&#8217;s Counsel&#8221; means the law firm of Robbins Geller Rudman &amp; Dowd LLP and any of its members, partners, associates and/or employees.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">8</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.10</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;Person&#8221; means an individual, corporation, limited liability company, professional corporation, limited liability partnership, partnership, limited partnership, association, joint venture, joint stock company, estate, legal representative, trust, unincorporated association, government or any political subdivision or agency thereof, and any business or legal entity, and each of their spouses, domestic partners, heirs, predecessors, successors, representatives, assigns, or assignees.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.11</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#32;&#8220;Plaintiffs&#8217; Counsel&#8221; means collectively Lead Plaintiff&#8217;s Counsel and Andrews &amp; Springer LLC and any attorney or firm who has appeared in the Action on behalf of any of the Plaintiffs.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.12</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;Related Parties&#8221; means (i) as to DaVita, each of its parents, subsidiaries and  affiliates, and each of their respective past or present directors, officers, managers, employees, partners, agents, affiliates, attorneys, advisors, members, accountants, auditors, banks, insurers, co-insurers, re-insurers, consultants, experts, successors, subsidiaries, divisions, joint ventures, assigns, general or limited partners or partnerships, limited liability companies, and any entity in which DaVita has a controlling interest, and (ii) as to the Settling Defendants, (1) each spouse, domestic partner, immediate family member, heir, executor, estate, administrator, agent, attorney, accountant, auditor, bank, insurer, co-insurer, re-insurer, advisor, consultant, or expert, of any of them in their capacity as such, (2)&#160;any trust in respect of which any Settling Defendant, or any spouse or family member thereof serves as a settlor, beneficiary or trustee, and (3) any entity in which a Settling Defendant, or any spouse or immediate family member thereof, holds a controlling interest or for which a Settling Defendant has served as an employee, director, officer, managing director, advisor, general partner, limited partner, or member and any collective investment vehicle which is </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">9</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">advised or managed by any of them and the legal or personal representatives of the foregoing, in their capacities as such.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.13</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;Released Claims&#8221; means all claims, demands, rights, duties, controversies, obligations, actions, debts, sums of money, suits, contracts, agreements, promises, damages, losses, judgments, liabilities, allegations, arguments, causes of action and claims for relief of every nature and description whatsoever, known or unknown (as set forth below), whether arising under federal, state, local, common, statutory, administrative or foreign law, or any other rule or regulation, at law or in equity, whether fixed or contingent, whether accrued or unaccrued, whether liquidated or unliquidated, whether matured or unmatured, that have been, and could have been, asserted in the Action or could have been asserted in any forum by Lead Plaintiff, DaVita, or any DaVita stockholder derivatively on behalf of DaVita against the Settling Defendants, based on the Settling Defendants&#8217; acts and/or omissions in connection with, arising out of, or relating to, the allegations, facts, transactions, events, matters, occurrences, acts, disclosures, statements, occurrences, representations or omissions or failures to act related to DaVita&#8217;s relationship with and contributions to the American Kidney Fund (&#8220;AKF&#8221;) and its policies and procedures regarding educating ESRD patients about charitable assistance from the AKF in the payment of insurance premiums that Lead Plaintiff alleges breached the Settling Defendants&#8217; fiduciary duties and violated certain federal laws through and including the date of execution of this Stipulation.  For the avoidance of doubt, the Released Claims shall not include the Securities Class Action pending in the United States District Court for the District of Colorado captioned </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">Peace Officers&#8217; Annuity and Benefit Fund of Ga. v. DaVita Inc. et al.</font><font style="font-family:inherit;font-size:12pt;">, No. 1:17-cv-00304-WJM-MJW (D. Co.).</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.14</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;Released Persons&#8221; means the Settling Defendants, DaVita and their respective Related Parties.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.15</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;Settlement&#8221; means this agreement.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.16</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;Settling Defendants&#8221; means Kent J. Thiry, Pamela M. Arway, Charles G. Berg, Carol Anthony &#8220;John&#8221; Davidson, Barbara J. Desoer, Paul J. Diaz, Peter T. Grauer, John M. Nehra, William L. Roper, Roger J. Valine, Robert J. Margolis, Garry E. Menzel, and James K. Hilger.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.17</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;Settling Parties&#8221; means, collectively, each of the Lead Plaintiff, the Settling Defendants and DaVita.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.18</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;Stipulation&#8221; means this agreement.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.19</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#8220;Unknown Claims&#8221; means any Released Claims which Lead Plaintiff, DaVita or a DaVita stockholder does not know or suspect to exist in his, her or its favor at the time of the release such claims against the Released Persons, including claims which, if known by him, her or it, might have affected his, her or its settlement with, and release of the Released Persons, or might have affected his, her or its decision(s) with respect to the Settlement, including, but not limited to, whether or not to object to this Settlement or to the release of any Released Claims.  With respect to any and all Released Claims, the Settling Parties stipulate and agree that, upon the Effective Date, Plaintiffs, DaVita, and its stockholders shall be deemed to have, and by operation of the Judgment shall have, expressly waived, the provisions, rights and benefits of California Civil Code &#167;1542, which provides:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">11</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Further, the Settling Parties stipulate and agree that, upon the Effective Date, each of the Released Persons also shall expressly waive, and by operation of the Judgment shall have expressly waived any and all provisions, rights and benefits conferred by any law of any jurisdiction or any state or territory of the United States, or principle of common law, which is similar, comparable or equivalent to California Civil Code &#167;1542.  Lead Plaintiff, DaVita and each DaVita stockholder may hereafter discover facts in addition or different from those which he, she, it or their counsel now knows or believes to be true with respect to the subject matter of the Released Claims, but the Lead Plaintiff, DaVita and each DaVita stockholder derivatively on behalf of DaVita, upon the Effective Date, shall be deemed to have, and by the operation of the Judgment shall have fully, finally and forever settled and released all Released Claims, known or unknown, suspected or unsuspected, contingent or non-contingent, whether or not concealed or hidden, which now exist, or heretofore have existed upon any theory of law or equity now existing or coming into existence in the future, including, but not limited to, conduct which is negligent, intentional, with or without malice, or a breach of any duty, law or rule, without regard to the subsequent discovery or existence of such different or additional facts.  The Settling Parties acknowledge, and the DaVita stockholders shall be deemed by operation of the Judgment to have acknowledged, that the foregoing waiver was separately bargained for and is a key element of the Settlement of which this release is a part.</font></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Consideration</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.1</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">In connection with the Settlement of the Action, the Settling Defendants shall cause insurers to make a cash payment of $50,000,000 to DaVita (the &#8220;Settlement Payment&#8221;) in the manner described in &#182;2.3.  In addition, within forty-five (45) days after the Final </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">12</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Approval Order for the proposed Settlement is entered by the Court,  DaVita Inc.&#8217;s Board of Directors (&#8220;Board&#8221;) shall adopt and maintain the Corporate Governance Policies set forth in &#182;2.4 below, which shall remain in effect at least five (5) years.  Notwithstanding anything to the contrary herein, the Board shall not be restricted from acting as necessary in order to discharge its fiduciary duties, subject to the limitations and restrictions imposed by the Order of the Court approving this Settlement.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.2</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">DaVita acknowledges and agrees that the Settlement Payment and implementation of the Corporate Governance Policies set forth in &#182;2.4 below confer substantial benefits upon DaVita and its stockholders.  DaVita acknowledges that the commencement, prosecution, and settlement of the Action were material and the precipitating factors in the Company&#8217;s ability to receive the Settlement Payment and in the Board&#8217;s decision to adopt, implement, and maintain the Corporate Governance Policies set forth in &#182;2.4 below.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.3</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Settlement Payment shall be paid into an interest-bearing escrow account (&#8220;Escrow Account&#8221;) within fifteen (15) business days of the Court&#8217;s entry of the Preliminary Approval Order described in &#182;3.1 below.  The Escrow Account shall be controlled by an agreed upon representative of Plaintiffs and of the Settling Defendants on terms to be agreed to in an escrow agreement governing the Escrow Account.  The Escrow Account shall be held at Citi Private Bank and established with DaVita&#8217;s tax identification number.  Within fifteen (15) business days after entry of the Final Approval Order by the Court, the funds remaining in the Escrow Account including interest thereon and after payment of the Fee and Expense Amount (as defined in &#182;5.1) shall be released to DaVita notwithstanding the existence of any timely filed objections to the Final Approval Order, or potential for appeal therefrom, or collateral attack on the Settlement or any part thereof, subject to DaVita&#8217;s </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">13</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">obligation to make appropriate refunds or repayments if, as a result of any appeal and/or further proceedings on remand, or successful collateral attack, approval of the Settlement is denied or overturned.  </font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.4&#160;&#160;&#160;&#160;The Corporate Governance Policies:</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Within forty five (45) days of issuance of an order approving the settlement by the United States District Court for the District of Delaware, DaVita Inc.&#8217;s (&#8220;DaVita&#8221; or the &#8220;Company&#8221;) Board of Directors (&#8220;Board&#8221;) shall adopt resolutions and amend committee Charters and/or its Corporate Governance Guidelines and/or applicable corporate policies to ensure adherence to the following Corporate Governance Reforms, which shall remain in effect for no less than five (5) years. Notwithstanding anything to the contrary herein, the Board shall not be restricted from acting as necessary in order to discharge its fiduciary duties, subject to the limitations and restrictions imposed by the Order of the Court approving this Settlement.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">DaVita acknowledges and agrees that Plaintiffs City of Warren Police and Fire Retirement System and Charles Blackburn (&#8220;Derivative Plaintiffs&#8221;) were a precipitating and material factor in the adoption and implementation of the Corporate Governance Reforms set forth herein.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ACTIONS TAKEN SINCE THE DERIVATIVE ACTION WAS COMMENCED</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Changes to Board Composition - Resignation of Certain Directors.  Three of the Company&#8217;s long-term directors have resigned.  These Director resignations include: Kent J. Thiry (served since 1999); Peter T. Grauer (served since 1994), and Dr. William M. Roper (served since 2001).</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">14</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">2.&#160;&#160;&#160;&#160;DIRECTOR TENURE AND BOARD REFRESHMENT </font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">At the time of filing this lawsuit, the range of tenure for the directors was 22 years to less than one year, with four of the directors with a tenure over fifteen years.  Based on discussion with Plaintiffs&#8217; counsel, the Board agreed to adopt corporate governance guidelines that require the average tenure of the independent members of the Board of Directors as calculated on July 1 of each year to be no longer than twelve (12) years.  The average shall be determined by adding the tenure of each independent director and dividing the result by the number of independent directors.  The term of a Director serving less than one year shall be determined by dividing the number of months such Director has been on the DaVita Board by twelve (12). Starting in 2021, to the extent that the DaVita Board determines to decide to add new members to the DaVita Board as set forth above in this paragraph, any such new director shall be identified, screened and appointed or nominated to the DaVita Board pursuant to the procedure set forth below:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Chair of the Nominating and Governance Committee (&#8220;N&amp;G Chair&#8221;) shall establish an objective set of criteria to be utilized in conducting the board search process detailed herein (&#8220;Board Search Criteria&#8221;).  In developing the Board Search Criteria, the N&amp;G Chair will consider feedback received from shareholders over the course of the Company&#8217;s shareholder outreach throughout the year and any other feedback received from any shareholder as appropriate;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The N&amp;G Chair shall provide Plaintiffs&#8217; corporate governance expert the proposed Board Search Criteria in advance of starting the board director search to receive comments and feedback, which shall be </font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;padding-left:96px;text-align:justify;"><font style="font-family:inherit;font-size:12pt;">incorporated as the Nominating &amp; Governance Committee deems appropriate in its business judgment, into the Board Search Criteria.  Disputes regarding the appropriateness of any Board Search Criteria shall be promptly resolved via binding mediation before the Honorable Layn R. Phillips; </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">A pool of prospective candidates will be developed by the Company with reference to the Board Search Criteria.  An appropriate review, including background information and interviews of prospective candidates, shall be conducted with respect to all candidates identified through this process who express their consent to being considered and to serving as a director. No fewer than three (3) qualified candidates shall be sent to the Nominating and Governance Committee for review.</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;&#32;</font><font style="font-family:inherit;font-size:12pt;">If the combined gender and ethnic/racial diversity of the Board falls below 50%, then at least two (2) of these candidates shall be members of an underrepresented group, thereby ensuring that members of the populations underrepresented on the Board are considered for nomination to the DaVita Board.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">After considering the candidates submitted for review, if the Nominating and Governance Committee identifies any candidates to move forward to the Board for further consideration, it shall identify at least two (2) candidates from those submitted for review for consideration by the Board, based on the business judgment of the Nominating and Governance Committee&#8217;s members considering the </font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">16</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;padding-left:96px;text-align:justify;"><font style="font-family:inherit;font-size:12pt;">information provided by the Plaintiffs&#8217; corporate governance expert in Section (b) above.</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(e)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Once the candidates are identified by the Nominating and Governance Committee, the Board shall, subject to its business judgment and Section 2(f), decide which candidate(s) to nominate for election to the Board or, if no shareholders&#8217; meeting is scheduled in the next 90 days, the Board shall elect the candidate(s) to fill any Board vacancies until such meeting is held and the candidate(s) can be nominated for election by shareholders.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(f)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In the event the Board decides that no candidate should be nominated via the process detailed in paragraphs (a)-(e) above, the process shall be repeated for any director position sought to be filled pursuant thereto.  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(g)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If a director appointed to the Board through the process detailed in paragraphs (a)-(e) above is no longer able to serve on the Board, the process described above shall be repeated for the selection of a replacement director.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(h)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The parties agree the director tenure and board refreshment process and procedures set forth above will result in the addition of no less than one new member to the Board during the term of this Agreement and, as a result, the Company shall add at least one new member to the Board prior to the Company&#8217;s Annual Stockholder Meeting in 2025. </font></div></td></tr></table><div style="line-height:240%;text-align:justify;padding-left:96px;text-indent:-48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">17</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">3.&#160;&#160;&#160;&#160;CLAWBACK POLICY</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Clawbacks reduce financial misreporting and significantly improve the integrity of financial reporting, thereby enhancing shareholder value.  The Company shall implement a claw-back policy that includes the following:</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)&#160;&#160;&#160;&#160;A provision requiring the Company to &#8220;claw-back&#8221; incentive-based compensation paid to the Company&#8217;s CEO or CFO in the event of a material accounting restatement of the Company&#8217;s financial statements due to the material noncompliance of the Company with any financial reporting requirement under federal and/or state securities laws.  The amount to be recouped pursuant to this provision shall be calculated as the excess amount of incentive-based compensation paid to such officer during the one-year period preceding the date the applicable financial statement restatement is disclosed (the &#8220;Covered Period&#8221;) on the basis of the erroneous results over the amount of incentive-based compensation such officer would have received during the Covered Period had the financial results been properly reported;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)&#160;&#160;&#160;&#160;A provision authorizing the Board to exercise discretion to &#8220;claw-back&#8221; incentive-based compensation paid to any of the Company&#8217;s NEOs in the event of a material accounting restatement of the Company&#8217;s financial statements due to the material noncompliance of the Company with any financial reporting requirement under federal and/or state securities laws.  The amount to be recouped pursuant to this provision shall not exceed the excess amount of incentive-based compensation paid to such officer during </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">18</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">the Covered Period on the basis of the erroneous results over the amount of incentive-based compensation such officer would have received during the Covered Period had the financial results been properly reported; </font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)&#160;&#160;&#160;&#160;A provision authorizing the Company to exercise discretion to &#8220;claw-back&#8221; incentive-based compensation paid to any of the Company&#8217;s employees whose position is equivalent to or above a senior vice president in the Company&#8217;s domestic business (a &#8220;Covered Employee&#8221;) in the event of his or her &#8220;Significant Misconduct&#8221; (defined as a material violation of applicable law or significant Company policy by such Covered Employee that would have rendered him or her ineligible for an annual bonus or long-term incentive compensation program award in that program year or subsequent program years). To the extent that a Covered Employee is determined by the Company to have been involved in any Significant Misconduct, such Covered Employee shall be at risk of recoupment of an amount equivalent to up to three years of his or her annual incentive compensation for a period of three years from the date of the Significant Misconduct; and,</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)&#160;&#160;&#160;&#160;Any amounts clawed-back pursuant to paragraphs (a)-(c) above shall be repaid within twelve (12) months of the determination that such recoupment is required and shall be net of any unreturnable taxes.</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">4.&#160;&#160;&#160;&#160;NON-EXECUTIVE CHAIR OF THE BOARD </font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">For at least four years from the execution of this Agreement, the DaVita Board shall have a Non-Executive Chair.  Toward this end, the DaVita Board shall include a provision </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">19</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">in the Company&#8217;s Corporate Governance Guidelines which requires that, beginning on June&#160;1, 2021, the Chair of the Board shall be an independent director.  The position of Chair shall not be held by an executive officer, including the Chief Executive Officer of DaVita.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;&#160;</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">POLICY ON POLITICAL AND LOBBYING EXPENDITURES </font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">A.&#160;&#160;&#160;&#160;The Company shall publish its Policy Related to Political and Lobbying Expenditures (&#8220;Policy&#8221;), which shall include the following provisions relevant to political lobbying:</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Board shall have oversight of the Company&#8217;s lobbying expenditures or activities, which are conducted solely for promoting the long-term commercial, environmental, social and governance interests of the Company and/or promoting the interests of our patients and the Company, and aligns with the public policy goals of the Company;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Material breaches of the Policy that are reported to the Government Affairs team or senior management will be reported to the Board of Directors;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Board shall have oversight of the Policy, including lobbying spending as it relates to the long-term commercial, environmental, social and governance interests of the Company, its patients and its stockholders;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Lobbying expenditures are made without regard for the personal political preferences of the Company executives, including its directors and/or officers.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">B.&#160;&#160;&#160;&#160;The Company shall publish its Policy, which shall include the following provisions related to political expenditures:</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Company&#8217;s lobbying and political expenditures are focused on promoting the long-term commercial, environmental, social and governance </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">interests of the Company and/or promoting the interests of our patients, and align with the public policy goals of the Company;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Company does not pressure or coerce employees to make personal political expenditures or take any retaliatory action against employees who do not;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Company&#8217;s political spending is made without regard for the personal political preferences of the Company executives, including its directors and/or officers;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Material breaches of the Policy that are reported to the Government Affairs team or senior management will be reported to the Board of Directors;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Board shall have oversight of the Policy, including political spending as it relates to the long-term commercial, environmental, social and governance interests of the Company, its patients, and its stockholders.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">C.&#160;&#160;&#160;&#160;The Company shall provide easy access to the publicly available information by including links on its website to the following (as directly to the information as practical):</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">6.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">DaVita Political Action Committee (&#8220;DaPAC&#8221;), disbursements which are reported on the Federal Election Commission&#8217;s website;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Federal and State lobbying reports; </font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">8.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Applicable state level campaign finance reports.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">D.&#160;&#160;&#160;&#160;The full Board, rather than a Public Policy Committee, shall oversee public policy priorities and advocacy efforts, including related expenditures.   </font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">E.&#160;&#160;&#160;&#160;The Company shall post a report updated semi-annually that includes the following (&#8220;Report&#8221;):</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">21</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">9.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Links (as directly to the information as practical) to the federal and state disclosure forms describing the amount contributed by DaVita (or any entity owned or operated by DaVita such as DaPAC) to political parties, candidates or other entities;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">10.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">List of the top five trade associations to whom DaVita pays funds, explaining that &#8220;DaVita contributes to trade associations that may engage in lobbying activities on the Company&#8217;s behalf to advance the public policy interests of the Company, its patients, teammates and stockholders.  The top five trade associations to which we contribute are: . . .&#8221;;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">11.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">An explanation of the reason for DaVita&#8217;s contributions and the long-term policies described herein which are supported by the top ten contributions identified in Section E(1), with the link (as directly to the information as practical) adjacent to the explanation;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">12.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">A high level description of DaVita&#8217;s position on key policy priorities to help ensure that related positions are within the scope of the Company&#8217;s business and in the best interests of the Company and its stockholders (</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">e.g.</font><font style="font-family:inherit;font-size:12pt;">&#32;&#8220;Our lobbying efforts are intended to, among other things, help effectuate the Company&#8217;s policy priorities with respect to end state renal disease (ESRD) reimbursement, eligibility criteria and network adequacy.&#8221;);</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">F.&#160;&#160;&#160;&#160;The Company will post the Policy and Report in a conspicuous place on the DaVita.com website for easy accessibility.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">DIRECTOR INDEPENDENCE</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Board shall ensure that at least two-thirds (66.67%) of the members of the Board shall be &#8220;independent&#8221; directors, as defined by the New York Stock Exchange requirements.  </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">22</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">To be deemed independent in any calendar year for this purpose, a director must also satisfy the following standards:</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)&#160;&#160;&#160;&#160;The director is not, and has not been within the last four (4) calendar years, an employee of the Company or one of its wholly-owned subsidiaries and an &#8220;immediate family member&#8221; (as defined in NYSE Listed Company Manual Section 303A.02) of the director is not, and has not been within the last four (4) calendar years, an executive officer as defined in Rule 3b-7 of the Exchange Act, (an &#8220;Exchange Act Executive Officer&#8221;) of the Company;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)&#160;&#160;&#160;&#160;During the current calendar year or any of the three (3) immediately preceding calendar years, the director has not been paid by the Company more than $120,000 in compensation for services, other than for services rendered as a director;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)&#160;&#160;&#160;&#160;The director is not employed as an Exchange Act Executive Officer of another public company on whose board of directors any of DaVita&#8217;s current Exchange Act Executive Officers serve.</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Settlement Procedures</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.1</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">After execution of this Stipulation, Lead Plaintiff shall submit the Stipulation together with its Exhibits to the Court and shall move for entry of an order substantially in the form of Exhibit A hereto (the &#8220;Preliminary Approval Order&#8221;), requesting, among other things, the preliminary approval of the Settlement set forth in the Stipulation, and approval for the filing and publication of the Settlement Notice, substantially in the forms attached hereto as Exhibits A-1 (&#8220;Notice&#8221;) and A-2 (&#8220;Summary Notice&#8221;; the Notice and Summary Notice collectively, the &#8220;Settlement Notice&#8221;), which shall include the general terms of the </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">23</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Settlement set forth in the Stipulation and the date of the Settlement Hearing as described below.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.2</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Within five (5) business days of the issuance by the Court of an Order preliminarily approving the Settlement, DaVita shall cause the Stipulation and Notice to be furnished to the Securities and Exchange Commission via a Form 8-K, shall publish the Summary Notice for one day in </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">Investors&#8217; Business Daily</font><font style="font-family:inherit;font-size:12pt;">, and shall post the Stipulation and Notice on DaVita&#8217;s website at https://investors.davita.com/ such that visitors to the &#8220;Investors&#8221; section of the website, until entry of the Final Approval Order, will readily find a hyperlink to the Notice.  The Company shall pay for reasonable costs, if any, of providing reasonable notice of the Settlement, in the form approved by the Court.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.3</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Lead Plaintiff will also request that forty-five (45) calendar days after the Settlement Notice is disseminated, the Court hold a hearing (the &#8220;Settlement Hearing&#8221;) to consider and determine whether the Final Approval Order and the Judgment, substantially in the forms of Exhibits B and C hereto, should be entered: (a) approving the terms of the Settlement as fair, reasonable and adequate; and (b) dismissing with prejudice the Action against the Settling Defendants.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.4</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Pending the Effective Date, all proceedings and discovery in the Action shall be stayed except as otherwise provided herein, and the Settling Parties shall not file or prosecute any other Action or proceedings relating to the claims asserted in the Action.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Releases</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.1</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Upon the Effective Date, DaVita, each of DaVita&#8217;s stockholders and the Lead Plaintiff (acting on their own behalf and derivatively on behalf of DaVita), for good and sufficient consideration, the receipt and adequacy of which is hereby acknowledged, shall </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">24</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">be deemed to have, and by operation of law and the Judgment shall have, fully, finally, and forever compromised, settled, released, resolved, relinquished, waived  and discharged and dismissed with prejudice each and every Released Claim (including Unknown Claims) against the Released Persons.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.2</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Upon the Effective Date, each of the Released Persons and the Related Parties, for good and sufficient consideration, the receipt and adequacy of which is hereby acknowledged, shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished and discharged each and all of Plaintiffs and Plaintiffs&#8217; Counsel and all current DaVita stockholders (solely in their capacity as DaVita stockholders) from all claims (including Unknown Claims) arising out of, relating to, or in connection with the institution, prosecution, assertion, settlement or resolution of the Action or the Released Claims.  Nothing herein shall in any way impair or restrict the rights of any Settling Party to enforce the terms of the Stipulation.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Lead Plaintiff&#8217;s Counsel&#8217;s Separately Negotiated Attorneys&#8217; Fees and Expenses</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5.1</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">After negotiating the principal terms of the Settlement, counsel for Lead Plaintiff and DaVita, acting by and through its counsel, with the assistance of Judge Phillips, separately negotiated the attorneys&#8217; fees and expenses the Company would pay to Plaintiffs&#8217; Counsel based on the substantial benefits conferred upon DaVita by the Settlement.  In light of the substantial benefits conferred by Plaintiffs&#8217; Counsel&#8217;s efforts, DaVita, acting by and through its Board of Directors, has agreed to pay $15,000,000 in attorneys&#8217; fees and expenses, subject to Court approval (the &#8220;Fee and Expense Amount&#8221;).  The Settling Parties acknowledge and agree that any Fee and Expense Amount the Court awards to Plaintiffs&#8217; </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">25</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Counsel shall be paid solely from the Settlement Payment, and that none of DaVita or the Settling Defendants or the Related Parties shall have any separate responsibility therefor. </font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5.2</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Upon final approval by the Court, the Fee and Expense Amount shall be paid from the Escrow Account to Robbins Geller Rudman &amp; Dowd LLP, as receiving agent for Plaintiffs&#8217; Counsel, within five (5) calendar days after entry of the Final Approval Order by the Court, notwithstanding the existence of any timely filed objections thereto, or potential for appeal therefrom, or collateral attack on the Settlement or any part thereof, subject to Plaintiffs&#8217; Counsel&#8217;s several obligation to make appropriate refunds or repayments if, and when, as a result of any appeal and/or further proceedings on remand, or successful collateral attack, approval of the Settlement is denied or overturned.  Neither DaVita nor any other Released Persons shall have any obligations with respect to Plaintiffs&#8217; Counsel&#8217;s fees and/or expenses beyond the Fee and Expense Amount which shall be paid solely from the Escrow Account.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5.3</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Neither DaVita nor the Settling Defendants shall have any responsibility or liability whatsoever with respect to the allocation of the attorneys&#8217; fees awarded in this matter among Plaintiffs&#8217; Counsel, or any other individual or entity asserting a right to recover any portion of the attorneys&#8217; fees awarded.  Any dispute regarding any allocation of fees or expenses among Plaintiffs&#8217; Counsel shall have no effect on the Settlement.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Conditions of Settlement; Effect of Disapproval, Cancellation or Termination</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">6.1</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Effective Date shall be conditioned on the occurrence of all of the following events:</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">26</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the DaVita Board of Directors has approved the Settlement and each of its terms, including the separately negotiated Fee and Expense Amount;</font></div><div style="line-height:240%;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the Court has entered the Final Approval Order and Judgment, substantially in the forms of Exhibits B and C attached hereto; and</font></div><div style="line-height:240%;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the Judgment has become Final.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">6.2</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">If any of the conditions specified in &#182;6.1 are not met, then the Stipulation of Settlement shall be canceled and terminated subject to the provisions of &#182;&#182;6.2 and 6.3, unless counsel for the Settling Parties mutually agree in writing to proceed with a renewed, alternative, or modified Stipulation and submit it for Court approval.  If for any reason the Effective Date does not occur, or if this Stipulation is terminated, or is cancelled, or otherwise fails to become effective for any reason:</font></div><div style="line-height:240%;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Settling Parties, Released Persons and Related Parties shall be restored to their respective positions that existed immediately prior to July 15, 2020;</font></div><div style="line-height:240%;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">All negotiations, proceedings, documents prepared and statements made in connection with this Stipulation shall be without prejudice to the Settling Parties, shall not be deemed or construed to be an admission by a Settling Party of any act, matter, or proposition and shall not be used in any manner for any purpose (other than to enforce the terms remaining in effect) in any subsequent proceeding in the Action or in any other action or proceeding; and</font></div><div style="line-height:240%;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The terms and provisions of the Stipulation, with the exception of the provisions of  &#182;5.2 and &#182;6.2  shall have no further force and effect with respect to the Settling Parties and shall not be used in the Action or in any other proceeding for any purpose, and any judgment or orders entered by the Court in accordance with the terms of the Stipulation shall be treated as vacated, </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">nunc pro tunc</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">27</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The appropriate respective amounts of the Settlement Payment including interest thereon shall be returned within fifteen (15) business days to the entities contributing to the Settlement Payment.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">6.3</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">No order of the Court or modification or reversal on appeal of any order of the Court concerning the amount of attorneys&#8217; fees, costs, expenses and interest awarded by the Court to Lead Plaintiff&#8217;s Counsel shall constitute grounds for cancellation or termination of the Stipulation, affect the enforceability of the Stipulation, or delay or preclude the Judgment from becoming Final.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">7.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Miscellaneous Provisions</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.1</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Settling Parties (a) acknowledge that it is their intent to consummate the terms and conditions of this Stipulation; and (b) agree to cooperate to the extent reasonably necessary to effectuate and implement all terms and conditions of the Stipulation and to exercise their best efforts to accomplish the foregoing terms and conditions of the Stipulation.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.2</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Settling Parties intend this Settlement to be a final and complete resolution of all Released Claims between Plaintiffs&#8217; and DaVita and its stockholders, on the one hand, and the Released Persons, on the other hand.  The Settlement compromises claims that are contested and shall not be deemed an admission by any Settling Party or Released Person as to the merits of any claim, allegation or defense.  The Final Approval Order shall contain a finding that during the course of the litigation, the parties and their respective counsel at all times complied with the requirements of Rule 11 of the Federal Rules of Civil Procedure and all other similar laws.  The Settling Parties further agree that the Released Claims are being settled voluntarily after consultation with competent legal counsel and an experienced mediator.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">28</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.3</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Pending the Effective Date, the Settling Parties agree not to initiate any proceedings concerning the Released Claims other than those incident to the settlement itself; provided, however, that DaVita and the Settling Defendants may seek to prevent or stay any other action or claims brought seeking to assert any Released Claims.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.4</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Any Settlement documentation, the Settlement, the Stipulation and any act performed or document executed pursuant to or in furtherance of any of the foregoing: (a)&#160;shall not be deemed to be or be offered, attempted to be offered or used in any way by the parties as a presumption, a concession or an admission of, or evidence of, any fault, wrongdoing or liability of the parties or the validity of any of the claims released in the Settlement; and (b) are not intended by the parties to be offered or received as evidence or used by any other person in any other actions or proceedings, whether civil, criminal or administrative, except as may be necessary to effectuate the Settlement or enforce a party&#8217;s rights under the Settlement.  Neither this Stipulation nor the Settlement shall be admissible in any proceeding for any purpose, except to enforce the terms of the Settlement, and except that the Released Persons may file or use the Stipulation, the Final Approval Order and/or the Judgment in any action that may be brought against them in order to support a defense or counterclaim based on principles of </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">res judicata</font><font style="font-family:inherit;font-size:12pt;">, collateral estoppel, full faith and credit, release, good faith settlement, standing, judgment bar or reduction or any other theory of claim preclusion or issue preclusion or similar defense or counterclaim.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.5</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">This Stipulation shall survive any Change of Control of the Company, regardless of the effect a change in control will otherwise have on the litigation, including on the Corporate Governance Provisions provided for herein.  For purposes of this Paragraph, &#8220;Change of Control&#8221; means the sale of all or substantially all the assets of the Company; any merger, consolidation or acquisition of the Company with, by or into another corporation, </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">29</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">entity or person; or any change in the ownership of more than fifty percent (50%) of the voting capital stock of the Company in one or more related transactions.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.6</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">All agreements made and orders entered during the course of the Action relating to the confidentiality of information or sealing of documents shall survive this Stipulation and the Judgment.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.7</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">All Exhibits to this Stipulation are material and integral parts hereof and are fully incorporated herein by this reference.  Notwithstanding the foregoing, in the event there exists a conflict or inconsistency between the terms of this Stipulation and the terms of any exhibit attached hereto, the terms of the Stipulation shall prevail.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.8</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">This Stipulation may be amended or modified only by a written instrument signed by or on behalf of all Settling Parties or their respective successors-in-interest.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.9</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">This Stipulation and the Exhibits attached hereto constitute the entire agreement among the Settling Parties and no representations, warranties or inducements have been made to any Settling Party concerning the Stipulation and/or any of its Exhibits, other than the representations, warranties and covenants contained and memorialized in such documents.  The Stipulation supersedes and replaces any prior or contemporaneous writing, statement or understanding pertaining to the Action and no parol or other evidence may be offered to explain, construe, contradict or clarify its terms, the intent of the Settling Parties or their counsel, or the circumstances under which the Stipulation was made or executed.  It is understood by the Settling Parties that, except for matters expressly represented herein, the facts or law with respect to which this Stipulation is entered into may turn out to be other than or different from the facts now known to each party or believed by such party to be true; each party therefore expressly assumes the risk of facts or law </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">turning out to be different, and agrees that this Stipulation shall be in all respects effective and not subject to termination by reason of any such different facts or law.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.10</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Except as otherwise expressly provided herein, all parties, including all Settling Defendants, their counsel, DaVita and its counsel, and Plaintiffs&#8217; and Plaintiffs&#8217; Counsel, shall bear their own fees, costs, and expenses.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.11</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Counsel for the Settling Parties are expressly authorized by their respective clients to take all appropriate action required or permitted to be taken pursuant to the Stipulation to effectuate its terms and conditions.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.12</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Lead Plaintiff represents and warrants it has not assigned or transferred, or attempted to assign or transfer, to any Person any Released Claim or any portion thereof or interest therein.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.13</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Each counsel or other Person executing this Stipulation or any of its Exhibits on behalf of any party hereto hereby warrants that such Person has the full authority to do so.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.14</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Any failure by any party to this Stipulation to insist upon the strict performance by any other party of any of the provisions of the Stipulation shall not be deemed a waiver of any of the provisions, and such party, notwithstanding such failure, shall have the right thereafter to insist upon the strict performance of any and all of the provisions of the Stipulation to be performed by such other party.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.15</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Stipulation and Exhibits may be executed in one or more counterparts.  A faxed or PDF signature shall be deemed an original signature for purposes of this Stipulation.  All executed counterparts including facsimile and/or PDF counterparts shall be deemed to be one and the same instrument.  A complete set of counterparts, either originally executed or copies thereof, shall be filed with the Court.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">31</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.16</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">This Stipulation shall be binding upon, and inure to the benefit of, the Settling Parties and their respective successors, assigns, heirs, spouses, marital communities, executors, administrators, trustees in bankruptcy and legal representatives.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.17</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Without affecting the finality of the Judgment entered in accordance with this Stipulation, the Court shall retain jurisdiction with respect to implementation and enforcement of the terms of the Stipulation, the Final Approval Order, and the Judgment, and the Settling Parties hereto submit to the jurisdiction of the Court for purposes of implementing and enforcing the Settlement embodied in the Stipulation, the Final Approval Order, and the Judgment and for matters arising out of, concerning or relating thereto.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.18</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">This Stipulation and the Exhibits hereto shall be considered to have been negotiated, executed and delivered, and to be wholly performed, in the State of Delaware, and the rights and obligations of the Settling Parties to the Stipulation shall be construed and enforced in accordance with, and governed by, the internal substantive laws of the State of Delaware without giving effect to Delaware&#8217;s choice-of-law principles.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.19</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">For the avoidance of doubt, each of the Related Parties is an intended third-party beneficiary of the relevant Releases in this Stipulation and has standing to enforce the relevant Releases in this Stipulation and may file this Stipulation and/or the Judgment from this Action in any other action that may be brought against them in order to support a defense or counterclaim based on principles of </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">res judicata</font><font style="font-family:inherit;font-size:12pt;">, collateral estoppel, full faith and credit, release, good faith settlement, standing, judgment bar reduction, or any other theory of claim preclusion or issue preclusion or similar defense or counterclaim.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.20</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The headings herein are used for the purpose of convenience only and are not intended to have legal effect.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">32</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.21</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">This Stipulation shall not be construed more strictly against one Settling Party than another merely by virtue of the fact that it, or any part of it, may have been prepared by counsel for one of the Settling Parties, it being recognized that the Stipulation is the result of arm&#8217;s-length negotiations between the Settling Parties and all Settling Parties have contributed substantially and materially to the preparation of this Stipulation.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">IN WITNESS WHEREOF, the Settling Parties have caused the Stipulation to be executed, by themselves and/or by their duly authorized attorneys, dated October 23, 2020.</font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:45%;"></td><td style="width:55%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">Of Counsel</font><font style="font-family:inherit;font-size:12pt;">:</font></div><div style="padding-bottom:16px;padding-top:16px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ROBBINS GELLER RUDMAN</font><font style="font-family:inherit;font-size:10pt;">&#160;<br></font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&amp; DOWD LLP</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;text-decoration:underline;">/s/ Benny C. Goodman, III</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Benny C. Goodman III <br>Erik Luedeke <br>655 West Broadway, Suite 1900 <br>San Diego, CA 92101 <br>(619) 231-1058</font><font style="font-family:inherit;font-size:10pt;">&#160;<br></font></div><div style="padding-top:16px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">Lead Counsel for Plaintiffs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ANDREWS &amp; SPRINGER LLC</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Peter B. Andrews (#4623) <br>Craig J. Springer (#5529) <br>David M. Sborz (#6203) <br>3801 Kennett Pike</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Building C, Suite 305 <br>Wilmington, DE 19807</font><font style="font-family:inherit;font-size:10pt;">&#160;<br></font><font style="font-family:inherit;font-size:12pt;">(302) 504-4957</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">pandrews@adrewsspringer.com <br>cspringer@adrewsspringer.com <br>dsborz@adrewsspringer.com</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">Delaware Counsel for Plaintiffs</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:16px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">VANOVERBEKE MICHAUD</font><font style="font-family:inherit;font-size:10pt;">&#160;<br></font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&amp; TIMMONY, P.C. <br>Thomas C. Michaud <br>79 Alfred Street <br>Detroit, MI 48201 <br>(313) 578-1200</font></div><div style="padding-top:16px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">Additional Counsel for Plaintiffs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">33</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.76851851851852%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:45%;"></td><td style="width:55%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">Of Counsel</font><font style="font-family:inherit;font-size:12pt;">:</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">MORGAN, LEWIS  <br>     &amp; BOCKIUS LLP</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Marc J. Sonnefeld</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Karen Pieslak Pohlmann</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Laura H. McNally</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1701 Market Street</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Philadelphia, PA 19103-2921</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(215) 963-5000</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:16px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">MORGAN, LEWIS &amp; BOCKIUS LLP</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;text-decoration:underline;">/s/ Jody C. Barillare</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Jody C. Barillare (#5107)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1201 N. Market Street, Suite 2201 <br>Wilmington, DE 19801</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(302) 574-3000</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">jody.barillare@morganlewis.com</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">Counsel for Nominal Defendant DaVita Inc.</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:45%;"></td><td style="width:55%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">MORRIS, NICHOLS, ARSHT</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&amp; TUNNELL, LLP</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;text-decoration:underline;">/s/ William Lafferty</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">William M. Lafferty (#2755)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Ryan D. Stottmann (#5237)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Elizabeth A. Mullin (#6380)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1201 N. Market Street, Suite 1800 <br>Wilmington, DE  19801</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(302) 658-9200</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">wlaffterty@mnat.com</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">rstottmann@mnat.com</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">emullin@mnat.com</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">Counsel for Defendants Kent J. Thiry, Pamela M. Arway, Charles G. Berg, Carol Anthony &#8220;John&#8221; Davidson, Barbara J. Desoer, Paul J. Diaz, Peter T. Grauer, John M. Nehra, William L. Roper, Roger J. Valine, Robert J. Margolis, Garry E. Menzel, and James K. Hilger</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Dated:  October 23, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">34</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ex992-noticeofproposed.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s7DB2790AC06E35273C8FB9195251353D"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT  99.2</font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">EXHIBIT A-1</font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">IN THE UNITED STATES DISTRICT COURT</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">FOR THE DISTRICT OF DELAWARE</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.3076923076923%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:50%;"></td><td style="width:4%;"></td><td style="width:46%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In re DaVITA INC. STOCKHOLDER DERIVATIVE LITIGATION</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="padding-top:16px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Document Relates To:</font></div><div style="padding-top:16px;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ALL ACTIONS.</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Civil Action No. 1:17-cv-00152-MPT</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">NOTICE OF PROPOSED DERIVATIVE SETTLEMENT</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">TO:</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF THE COMMON STOCK OF DAVITA, INC. (&#8220;DAVITA&#8221; OR THE &#8220;COMPANY&#8221;) AS OF OCTOBER 23, 2020 (THE &#8220;RECORD DATE&#8221;)</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY.  THIS NOTICE RELATES TO A PROPOSED SETTLEMENT AND DISMISSAL OF THE ABOVE-CAPTIONED DERIVATIVE ACTION (THE &#8220;ACTION&#8221;) AND CONTAINS IMPORTANT INFORMATION REGARDING YOUR RIGHTS.  YOUR RIGHTS MAY BE AFFECTED BY THESE LEGAL PROCEEDINGS.  IF THE COURT APPROVES THE SETTLEMENT, YOU WILL BE FOREVER BARRED FROM CONTESTING THE APPROVAL OF THE PROPOSED SETTLEMENT AND FROM PURSUING THE RELEASED CLAIMS.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">IF YOU HOLD DAVITA COMMON STOCK FOR THE BENEFIT OF ANOTHER, PLEASE PROMPTLY TRANSMIT THIS DOCUMENT TO SUCH BENEFICIAL OWNER.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Notice is hereby provided to you of the proposed settlement (the &#8220;Settlement&#8221;) of this stockholder derivative litigation.  This Notice is provided by Order of the United States District Court for the District of Delaware (the &#8220;Court&#8221;).  It is not an expression of any opinion by the Court with respect to the truth of the allegations in the litigation or merits of the claims or defenses asserted by or against any party.  It is solely to notify you of the terms of the proposed Settlement, and your rights related thereto.  Capitalized terms not otherwise defined shall have the definitions set forth in a written Stipulation of Settlement, dated October 23, 2020 (&#8220;Stipulation&#8221;).  A link to the Form </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">8-K filed with the Securities and Exchange Commission containing the text of the Stipulation may be found on DaVita&#8217;s website at the Investor Relations page at https://investors.davita.com.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">I.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">WHY THE COMPANY HAS ISSUED THIS NOTICE</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Your rights may be affected by the Settlement of the action styled </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">In re DaVita, Inc. Stockholder Derivative Litigation</font><font style="font-family:inherit;font-size:12pt;">, Civil Action No. 1:17-cv-00152-MPT (D. Del.) (the &#8220;Action&#8221;).  Plaintiffs City of Warren Police and Fire Retirement System and Charles Blackburn (on behalf of themselves and derivatively on behalf of DaVita); Defendants Kent J. Thiry, Pamela M. Arway, Charles G. Berg, Carol Anthony &#8220;John&#8221; Davidson, Barbara J. Desoer, Paul J. Diaz, Peter T. Grauer, John M. Nehra, William L. Roper, Roger J. Valine, Robert J. Margolis, Garry E. Menzel, and James K. Hilger (together, &#8220;Settling Defendants&#8221;); and Nominal Party DaVita (together, the &#8220;Settling Parties&#8221;) have agreed upon terms to settle the above-referenced litigation and have signed the Stipulation setting forth those settlement terms.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On January 29, 2021, at 11:30 a.m., the Court will hold a remote hearing (the &#8220;Settlement Hearing&#8221;) in the Action via a Zoom video conference which will be accessible via the following link:https://rgrdlaw.zoom.us/j/94868686162?pwd=T1Zvcks2Y1p1bmFmUE44Tzh5NTBKUT09.  The purpose of the Settlement Hearing is to determine: (i)&#160;whether the terms of the Settlement are fair, reasonable and adequate, including the separately negotiated amount for Plaintiffs&#8217; Counsel&#8217;s attorneys&#8217; fees and expenses, and should be finally approved; (ii) whether a final judgment should be entered and the Action dismissed with prejudice pursuant to the Stipulation; and (iii) such other matters as may be necessary or proper under the circumstances.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">II.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">THE DAVITA DERIVATIVE LITIGATION</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">A.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Commencement and Consolidation of the Action</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Beginning on February 10, 2017, Plaintiffs City of Warren Police and Fire Retirement System and Charles Blackburn filed shareholder derivative actions on behalf of DaVita for violations of &#167;14(a) of the Securities Exchange Act of 1934, breach of fiduciary duty and other relief in the United States District Court for the District of Delaware.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On August 15, 2017, the Court, the Honorable Chief Magistrate Judge Mary Pat Thynge presiding, consolidated the actions.  On the same date, the Court appointed City of Warren Police and Fire Retirement System as Lead Plaintiff, Robbins Geller Rudman &amp; Dowd LLP was appointed Lead Counsel, and Andrews &amp; Springer LLC as Delaware counsel.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On September 29, 2017, Lead Plaintiff filed the operative Consolidated Complaint.  The Consolidated Complaint asserts claims against Defendants for breaches of fiduciary duties, unjust enrichment, corporate waste and violations of &#167;14(a) of the Securities Exchange Act of 1934.  &#182;1.</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">1</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;It further alleges that a pre-suit demand upon the DaVita Board is unnecessary because a majority of the directors: (i) consciously implemented a system designed to game the Affordable Care Act (&#8220;ACA&#8221;) by improperly steering end stage renal disease (&#8220;ESRD&#8221;) patients to private insurance in order to boost profits and hide their scheme from shareholders, both of which are not protected conduct under the business judgment rule; and (ii) face a substantial likelihood of liability for consciously allowing these practices to persist.  </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">Id.</font></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;">______________</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">1 </sup></font><font style="font-family:inherit;font-size:10pt;">All &#8220;&#182;__&#8221; and &#8220;&#182;&#182;___&#8221; references are to the Verified Consolidated Shareholder Derivative Complaint filed on September 29, 2017.  See D.I. 13.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">B.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Defendants&#8217; Motion to Stay and Motion to Dismiss</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On December 18, 2017, Defendants moved to dismiss the Consolidated Complaint for failure to sufficiently plead demand futility and separately moved to stay the consolidated actions pending the outcome of the motions to dismiss the related Securities Class Action pending in the United States District Court for the District of Colorado.  D.I. 20-25; </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">see</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">also</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">Peace Officers&#8217; Annuity and Benefit Fund of Ga. v. DaVita Inc. et al.</font><font style="font-family:inherit;font-size:12pt;">, No. 1:17-cv-00304-WJM-MJW (D. Co.).</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Lead Plaintiff opposed each motion on March 9, 2018.  D.I. 27.  Lead Plaintiff additionally moved to strike materials attached to and discussed in Defendants&#8217; memorandum of law in support of the motion to dismiss.  D.I.&#8217;s 28-29.  Defendants filed a reply in support of their motion to dismiss on May 4, 2018.  D.I.&#8217;s 33-34.  Defendants also separately filed an opposition to Lead Plaintiff&#8217;s motion to strike.  On June 25, 2018, the Court granted the motion to stay, which continued through status conferences on November 1, 2018 and January 7, 2019.  D.I.&#8217;s 37, 44.  On January 7, 2019, with no decision yet issued in the Securities Class Action, the Court ordered the parties to submit a joint proposed scheduling order, which the parties did on February 8, 2019.  D.I. 47.  The Court ordered the scheduling order into effect on February 28, 2019.  D.I. 48.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On April 25, 2019, this Court denied Defendants&#8217; motion to dismiss the derivative claims.  D.I. 50.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On May 28, 2019, Defendants and DaVita answered the Consolidated Complaint (D.I. 51, 52), and on June 12, 2019, the parties made their initial disclosures under Federal Rule of Civil Procedure 26(a)(l).  </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">See</font><font style="font-family:inherit;font-size:12pt;">&#32;D.I.&#8217;s 53, 53-55.  On August 16, 2019, the Court entered an updated scheduling order setting a fact discovery cutoff of July 24, 2020, an expert discovery cutoff of October 30, 2020, and a trial date of October 4, 2021.  </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">See</font><font style="font-family:inherit;font-size:12pt;">&#32;D.I. 62.  In light of the impact of the </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">COVID-19 pandemic and a ransom-ware attack on one of Defendants&#8217; discovery vendors, on May 12, 2020, the Court entered a further updated scheduling order setting the fact discovery cutoff of October 22, 2020, expert discovery cutoff of February 9, 2021, and a trial date to be determined after a decision is rendered on the case dispositive motions.  </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">See</font><font style="font-family:inherit;font-size:12pt;">&#32;D.I. 76.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">C.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Discovery</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On July 26, 2019, the Court conducted a scheduling teleconference, and on August 16, 2019, issued a Scheduling Order establishing a pre-trial schedule.  D.I. 62.  Thereafter, the parties began to engage in an extensive discovery process.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">As discovery progressed, Lead Plaintiff served written discovery on Defendants and issued subpoenas to third-parties.  As of today, Defendants have produced and Lead Plaintiff has reviewed and analyzed over 800,000 pages of documents.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">D.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Settlement Negotiations</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In the fall of 2019, the parties agreed to participate in a private mediation before the Honorable Layn R. Phillips (&#8220;Judge Phillips&#8221;), United States District Judge (Ret.).  The parties then participated in an in-person mediation session before Judge Phillips on September 25, 2019.  The September 2019 mediation was unsuccessful.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">While the parties pushed forward with the litigation and discovery, the Settling Parties continued to talk about resolution with the help of Judge Phillips.  After additional months of discovery, the Settling Parties engaged in a second mediation session with Judge Phillips on June 27, 2020.  While the Settling Parties did not reach an agreement to settle the Action at that session, </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">the Settling Parties continued negotiations with the assistance of Judge Phillips in parallel with ongoing discovery.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Ultimately, these efforts culminated with the Settling Parties accepting a mediators&#8217; proposal on July 15, 2020.  The settlement terms include a $50 million payment to the Company on behalf of the Individual Defendants and the Company agreeing to adopt certain Corporate Governance Policies set forth in III. below, subject to Court approval.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">E.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Approval of the Settlement by the DaVita Board</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On October 20, 2020, the DaVita Board, exercising its business judgment, unanimously approved the Settlement and each of its terms as providing a substantial benefit to the Company and, thus, being in the best interest of DaVita and its stockholders.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">III.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">TERMS OF THE PROPOSED DERIVATIVE SETTLEMENT</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The principal terms, conditions and other matters that are part of the Settlement, which is subject to approval by the Court, are summarized below.  This summary should be read in conjunction with, and is qualified in its entirety by reference to, the text of the Stipulation, which has been filed with the Court and is available at a link on DaVita&#8217;s website at the Investor Relations page at https://investors.davita.com.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In connection with the Settlement of the Action, Settling Defendants shall cause insurers to pay $50,000,000 (the &#8220;Settlement Payment&#8221;) to the Company.  In addition, in connection with the Settlement, the DaVita Board shall adopt the corporate governance measures specified herein within forty-five (45) days after the Final Approval Order for the proposed Settlement is entered by the Court, and maintain such measures for at least five (5) years.  DaVita acknowledges and agrees that </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">6</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">the Settlement Payment and implementation of the corporate governance policies set forth herein confer substantial benefits upon DaVita and its stockholders.  DaVita also acknowledges that the commencement, prosecution, and settlement of the Action were material and substantial factors in the Company&#8217;s ability to receive the Settlement Payment and in the Board&#8217;s decision to adopt, implement, and maintain the corporate governance reforms set forth below:</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Within forty five (45) days of issuance of an order approving the settlement by the United States District Court for the District of Delaware, DaVita&#8217;s Board of Directors (&#8220;Board&#8221;) shall adopt resolutions and amend committee Charters and/or its Corporate Governance Guidelines and/or applicable corporate policies to ensure adherence to the following Corporate Governance Reforms, which shall remain in effect for no less than five (5) years. Notwithstanding anything to the contrary herein, the Board shall not be restricted from acting as necessary in order to discharge its fiduciary duties, subject to the limitations and restrictions imposed by the Order of the Court approving this Settlement.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">DaVita acknowledges and agrees that Plaintiffs City of Warren Police and Fire Retirement System and Charles Blackburn (&#8220;Derivative Plaintiffs&#8221;) were a precipitating and material factor in the adoption and implementation of the Corporate Governance Reforms set forth herein.</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ACTIONS TAKEN SINCE THE DERIVATIVE ACTION WAS COMMENCED</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Changes to Board Composition - Resignation of Certain Directors.  Three of the Company&#8217;s long-term directors have resigned.  These Director resignations include: Kent J. Thiry (served since 1999); Peter T. Grauer (served since 1994), and Dr. William M. Roper (served since 2001).</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">DIRECTOR TENURE AND BOARD REFRESHMENT</font></div></td></tr></table><div style="line-height:240%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">At the time of filing this lawsuit, the range of tenure for the directors was 22 years to less than one year, with four of the directors with a tenure over fifteen years.  Based on discussion with Plaintiffs&#8217; counsel, the Board agreed to adopt corporate governance guidelines that require the average tenure of the independent members of the Board of Directors as calculated on July 1 of each year to be no longer than twelve (12) years.  The average shall be determined by adding the tenure of each independent director and dividing the result by the number of independent directors.  The term of a Director serving less than one year shall be determined by dividing the number of months such Director has been on the DaVita Board by twelve (12). Starting in 2021, to the extent that the DaVita Board determines to decide to add new members to the DaVita Board as set forth above in this paragraph, any such new director shall be identified, screened and appointed or nominated to the DaVita Board pursuant to the procedure set forth below:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Chair of the Nominating and Governance Committee (&#8220;N&amp;G Chair&#8221;) shall establish an objective set of criteria to be utilized in conducting the board search process detailed herein (&#8220;Board Search Criteria&#8221;).  In developing the Board Search Criteria, the N&amp;G Chair will consider feedback received from shareholders over the course of the Company&#8217;s shareholder outreach throughout the year and any other feedback received from any shareholder as appropriate;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The N&amp;G Chair shall provide Plaintiffs&#8217; corporate governance expert the proposed Board Search Criteria in advance of starting the board director search to receive comments and feedback, which shall be incorporated as the </font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">8</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;padding-left:96px;text-align:justify;"><font style="font-family:inherit;font-size:12pt;">Nominating &amp; Governance Committee deems appropriate in its business judgment, into the Board Search Criteria.  Disputes regarding the appropriateness of any Board Search Criteria shall be promptly resolved via binding mediation before the Honorable Layn R. Phillips; </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">A pool of prospective candidates will be developed by the Company with reference to the Board Search Criteria.  An appropriate review, including background information and interviews of prospective candidates, shall be conducted with respect to all candidates identified through this process who express their consent to being considered and to serving as a director. No fewer than three (3) qualified candidates shall be sent to the Nominating and Governance Committee for review.</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;&#32;</font><font style="font-family:inherit;font-size:12pt;">If the combined gender and ethnic/racial diversity of the Board falls below 50%, then at least two (2) of these candidates shall be members of an underrepresented group, thereby ensuring that members of the populations underrepresented on the Board are considered for nomination to the DaVita Board.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">After considering the candidates submitted for review, if the Nominating and Governance Committee identifies any candidates to move forward to the Board for further consideration, it shall identify at least two (2) candidates from those submitted for review for consideration by the Board, based on the business judgment of the Nominating and Governance Committee&#8217;s members considering the information provided by the Plaintiffs&#8217; corporate governance expert in Section (b) above.</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">9</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(e)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Once the candidates are identified by the Nominating and Governance Committee, the Board shall, subject to its business judgment and Section 2(f), decide which candidate(s) to nominate for election to the Board or, if no shareholders&#8217; meeting is scheduled in the next 90 days, the Board shall elect the candidate(s) to fill any Board vacancies until such meeting is held and the candidate(s) can be nominated for election by shareholders.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(f)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In the event the Board decides that no candidate should be nominated via the process detailed in paragraphs (a)-(e) above, the process shall be repeated for any director position sought to be filled pursuant thereto.  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(g)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If a director appointed to the Board through the process detailed in paragraphs (a)-(e) above is no longer able to serve on the Board, the process described above shall be repeated for the selection of a replacement director.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(h)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The parties agree the director tenure and board refreshment process and procedures set forth above will result in the addition of no less than one new member to the Board during the term of this Agreement and, as a result, the Company shall add at least one new member to the Board prior to the Company&#8217;s Annual Stockholder Meeting in 2025. </font></div></td></tr></table><div style="line-height:240%;text-align:justify;padding-left:96px;text-indent:-48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">3.&#160;&#160;&#160;&#160;CLAWBACK POLICY</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Clawbacks reduce financial misreporting and significantly improve the integrity of financial reporting, thereby enhancing shareholder value.  The Company shall implement a claw-back policy that includes the following:</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">A.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">A provision requiring the Company to &#8220;claw-back&#8221; incentive-based compensation paid to the Company&#8217;s CEO or CFO in the event of a material accounting restatement of the Company&#8217;s financial statements due to the material noncompliance of the Company with any financial reporting requirement under federal and/or state securities laws.  The amount to be recouped pursuant to this provision shall be calculated as the excess amount of incentive-based compensation paid to such officer during the one-year period preceding the date the applicable financial statement restatement is disclosed (the &#8220;Covered Period&#8221;) on the basis of the erroneous results over the amount of incentive-based compensation such officer would have received during the Covered Period had the financial results been properly reported;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)&#160;&#160;&#160;&#160;A provision authorizing the Board to exercise discretion to &#8220;claw-back&#8221; incentive-based compensation paid to any of the Company&#8217;s NEOs in the event of a material accounting restatement of the Company&#8217;s financial statements due to the material noncompliance of the Company with any financial reporting requirement under federal and/or state securities laws.  The amount to be recouped pursuant to this provision shall not exceed the excess amount of incentive-based compensation paid to such officer during the Covered Period on the basis of the erroneous results over the amount of incentive-based compensation such officer would have received during the Covered Period had the financial results been properly reported; </font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)&#160;&#160;&#160;&#160;A provision authorizing the Company to exercise discretion to &#8220;claw-back&#8221; incentive-based compensation paid to any of the Company&#8217;s employees whose position is equivalent to or above a senior vice president in the Company&#8217;s domestic business (a &#8220;Covered Employee&#8221;) in the event of his or her &#8220;Significant Misconduct&#8221; (defined as a </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">11</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">material violation of applicable law or significant Company policy by such Covered Employee that would have rendered him or her ineligible for an annual bonus or long-term incentive compensation program award in that program year or subsequent program years). To the extent that a Covered Employee is determined by the Company to have been involved in any Significant Misconduct, such Covered Employee shall be at risk of recoupment of an amount equivalent to up to three years of his or her annual incentive compensation for a period of three years from the date of the Significant Misconduct; and,</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)&#160;&#160;&#160;&#160;Any amounts clawed-back pursuant to paragraphs (a)-(c) above shall be repaid within twelve (12) months of the determination that such recoupment is required and shall be net of any unreturnable taxes.</font></div><div style="line-height:240%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">4.&#160;&#160;&#160;&#160;NON-EXECUTIVE CHAIR OF THE BOARD</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">For at least four years from the execution of this Agreement, the DaVita Board shall have a Non-Executive Chair.  Toward this end, the DaVita Board shall include a provision in the Company&#8217;s Corporate Governance Guidelines which requires that, beginning on June 1, 2021, the Chair of the Board shall be an independent director.  The position of Chair shall not be held by an executive officer, including the Chief Executive Officer of DaVita.  </font></div><div style="line-height:240%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">5.&#160;&#160;&#160;&#160;POLICY ON POLITICAL AND LOBBYING EXPENDITURES </font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">A.&#160;&#160;&#160;&#160;The Company shall publish its Policy Related to Political and Lobbying Expenditures (&#8220;Policy&#8221;), which shall include the following provisions relevant to political lobbying:</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1)&#160;&#160;&#160;&#160;The Board shall have oversight of the Company&#8217;s lobbying expenditures or activities, which are conducted solely for promoting the long-term commercial, environmental, social and governance interests of the Company and/or promoting the </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">12</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">interests of our patients and the Company, and aligns with the public policy goals of the Company;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2)&#160;&#160;&#160;&#160;Material breaches of the Policy that are reported to the Government Affairs team or senior management will be reported to the Board of Directors;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3)&#160;&#160;&#160;&#160;The Board shall have oversight of the Policy, including lobbying spending as it relates to the long-term commercial, environmental, social and governance interests of the Company, its patients and its stockholders;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4)&#160;&#160;&#160;&#160;Lobbying expenditures are made without regard for the personal political preferences of the Company executives, including its directors and/or officers.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">B.&#160;&#160;&#160;&#160;The Company shall publish its Policy, which shall include the following provisions related to political expenditures:</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1)&#160;&#160;&#160;&#160;The Company&#8217;s lobbying and political expenditures are focused on promoting the long-term commercial, environmental, social and governance interests of the Company and/or promoting the interests of our patients, and align with the public policy goals of the Company;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2)&#160;&#160;&#160;&#160;The Company does not pressure or coerce employees to make personal political expenditures or take any retaliatory action against employees who do not;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3)&#160;&#160;&#160;&#160;The Company&#8217;s political spending is made without regard for the personal political preferences of the Company executives, including its directors and/or officers;  </font></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4)&#160;&#160;&#160;&#160;Material breaches of the Policy that are reported to the Government Affairs team or senior management will be reported to the Board of Directors;</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">13</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5)&#160;&#160;&#160;&#160;The Board shall have oversight of the Policy, including political spending as it relates to the long-term commercial, environmental, social and governance interests of the Company, its patients, and its stockholders.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">C.&#160;&#160;&#160;&#160;The Company shall provide easy access to the publicly available information by including links on its website to the following (as directly to the information as practical):</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1)&#160;&#160;&#160;&#160;DaVita Political Action Committee (&#8220;DaPAC&#8221;), disbursements which are reported on the Federal Election Commission&#8217;s website;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2)&#160;&#160;&#160;&#160;Federal and State lobbying reports; </font></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3)&#160;&#160;&#160;&#160;Applicable state level campaign finance reports.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">D.&#160;&#160;&#160;&#160;The full Board, rather than a Public Policy Committee, shall oversee public policy priorities and advocacy efforts, including related expenditures.   </font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">E.&#160;&#160;&#160;&#160;The Company shall post a report updated semi-annually that includes the following (&#8220;Report&#8221;):</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1)&#160;&#160;&#160;&#160;Links (as directly to the information as practical) to the federal and state disclosure forms describing the amount contributed by DaVita (or any entity owned or operated by DaVita such as DaPAC) to political parties, candidates or other entities;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2)&#160;&#160;&#160;&#160;List of the top five trade associations to whom DaVita pays funds, explaining that &#8220;DaVita contributes to trade associations that may engage in lobbying activities on the Company&#8217;s behalf to advance the public policy interests of the Company, its patients, teammates and stockholders.  The top five trade associations to which we contribute are: . . .&#8221;;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3)&#160;&#160;&#160;&#160;An explanation of the reason for DaVita&#8217;s contributions and the long-term policies described herein which are supported by the top ten contributions identified in </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">14</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section E(1), with the link (as directly to the information as practical) adjacent to the explanation;</font></div><div style="line-height:240%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4)&#160;&#160;&#160;&#160;A high level description of DaVita&#8217;s position on key policy priorities to help ensure that related positions are within the scope of the Company&#8217;s business and in the best interests of the Company and its stockholders (e.g. &#8220;Our lobbying efforts are intended to, among other things, help effectuate the Company&#8217;s policy priorities with respect to end state renal disease (ESRD) reimbursement, eligibility criteria and network adequacy.&#8221;);</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">F.</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Company will post the Policy and Report in a conspicuous place on the DaVita.com website for easy accessibility.</font></div></td></tr></table><div style="line-height:240%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6.&#160;&#160;&#160;&#160;DIRECTOR INDEPENDENCE</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Board shall ensure that at least two-thirds (66.67%) of the members of the Board shall be &#8220;independent&#8221; directors, as defined by the New York Stock Exchange requirements.  To be deemed independent in any calendar year for this purpose, a director must also satisfy the following standards:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The director is not, and has not been within the last four (4) calendar years, an employee of the Company or one of its wholly-owned subsidiaries and an &#8220;immediate family member&#8221; (as defined in NYSE Listed Company Manual Section 303A.02) of the director is not, and has not been within the last four (4) calendar years, an executive officer as defined in Rule 3b-7 of the Exchange Act, (an &#8220;Exchange Act Executive Officer&#8221;) of the Company;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">During the current calendar year or any of the three (3) immediately preceding calendar years, the director has not been paid by the Company more than </font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;padding-left:96px;text-align:justify;"><font style="font-family:inherit;font-size:12pt;">$120,000 in compensation for services, other than for services rendered as a director;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:240%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The director is not employed as an Exchange Act Executive Officer of another public company on whose board of directors any of DaVita&#8217;s current Exchange Act Executive Officers serve.</font></div></td></tr></table><div style="line-height:240%;text-align:justify;padding-left:96px;text-indent:-48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">IV.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">LEAD PLAINTIFFS&#8217; COUNSEL&#8217;S SEPARATELY NEGOTIATED ATTORNEYS&#8217; FEES AND EXPENSES</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">After negotiating the principal terms of the Settlement, counsel for Lead Plaintiff and DaVita, acting by and through its counsel, with the assistance of the Honorable Layn R. Phillips (Ret.), separately negotiated the attorneys&#8217; fees and expenses that DaVita would pay to Plaintiffs&#8217; Counsel, subject to Court approval.  As a result of these negotiations, and in light of the substantial benefits conferred by Plaintiffs&#8217; Counsel&#8217;s efforts, DaVita, acting by and through its Board of Directors, has agreed to pay $15,000,000 in attorneys&#8217; fees and expenses, subject to Court approval (the &#8220;Fee and Expense Amount&#8221;).  The Fee and Expense Amount includes fees and expenses incurred by Plaintiffs&#8217; Counsel in connection with the prosecution and settlement of the Action.  To date, Plaintiffs&#8217; Counsel have not received any payments for their efforts on behalf of DaVita stockholders.  The Fee and Expense Amount will compensate Plaintiffs&#8217; Counsel for the substantial benefits achieved in the litigation.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">V.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">REASONS FOR THE SETTLEMENT</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Settling Parties have determined that it is desirable and beneficial that the Action, and all of their disputes related thereto, be fully and finally settled in the manner and upon the terms </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">16</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">and conditions set forth in the Stipulation and Plaintiffs&#8217; Counsel believe that the Settlement is in the best interests of the Settling Parties, DaVita and its stockholders.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">A.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Why Did the Settling Defendants Agree to Settle?</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Settling Defendants have denied and continue to deny each and every one of the claims and contentions alleged by Plaintiffs in the Action.  Each of the Settling Defendants expressly has denied and continues to deny any and all allegations of fault, wrongdoing, liability or damages whatsoever.  Settling Defendants expressly deny that Plaintiffs have asserted any valid claims as to any of them and expressly deny claims as to any of them arising out of, based upon or related to any of the conduct, statements, acts or omissions alleged, or that could have been alleged, in the Action.  Without limiting the foregoing, the Settling Defendants have denied and continue to deny, among other things, that they breached their fiduciary duties or any other duty owed to DaVita or its stockholders, or that Plaintiffs, DaVita, or its stockholders suffered any damage or were harmed as a result of any conduct alleged in the Action or otherwise.  The Settling Defendants have further asserted and continue to assert that at all relevant times, their conduct was proper and in compliance with all applicable provisions of law and believe the evidence developed to date supports their position that they acted in good faith and in a manner they reasonably believed to be in the best interests of DaVita and its stockholders and that the Action is without merit.  In addition, Settling Defendants maintain that they have meritorious defenses to all claims alleged in the Action and that DaVita&#8217;s existing corporate governance policies were not deficient.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Nonetheless, the Settling Defendants also have taken into account the expense, uncertainty and risks inherent in any litigation, especially in a complex case like the Action.  Therefore, the Settling Defendants have determined that it is desirable and beneficial that the Action, and all of </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">17</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">the Settling Parties&#8217; disputes related thereto, be fully and finally settled in the manner and upon the terms and conditions set forth in the Stipulation.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">B.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Why Did Plaintiffs Agree to Settle?</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Plaintiffs and their counsel believe that the claims asserted in the Action have merit.  However, Plaintiffs and their counsel recognize and acknowledge the expense and length of continued proceedings necessary to prosecute the Action against the Settling Defendants through trial and appeal.  Plaintiffs and their counsel also have taken into account the uncertain outcome and the risk of any litigation, especially in complex actions such as the Action, as well as the difficulties and delays inherent in such litigation.  Plaintiffs and their counsel also are mindful of the inherent problems of proof of, and possible defenses to, the violations asserted in the Action.  Based on Plaintiffs&#8217; and their counsel&#8217;s understanding of the facts, Plaintiffs and their counsel believe the Settlement provides an outstanding recovery based on the alleged conduct of the Settling Defendants.  Based on their evaluation, Plaintiffs and their counsel have determined that the Settlement set forth in the Stipulation is in the best interests of DaVita and its stockholders.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">VI.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SETTLEMENT HEARING</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On January 29, 2021, at 11:30 a.m., the Court will hold the Settlement Hearing remotely via a Zoom video conference which can be accessed through the following link: https://rgrdlaw.zoom.us/j/94868686162?pwd=T1Zvcks2Y1p1bmFmUE44Tzh5NTBKUT09 .  At the Settlement Hearing, the Court will consider whether the terms of the Settlement are fair, reasonable and adequate and thus should be finally approved, whether the separately negotiated Fee and Expense Amount should be approved and whether the Action should be dismissed with prejudice pursuant to the Stipulation.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">18</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Pending determination of whether the Settlement should be approved, no DaVita stockholder, either directly, representatively, derivatively or in any other capacity, shall commence or prosecute against any of the Released Persons, any action or proceeding in any court, administrative agency or other tribunal asserting any of the Released Claims.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">VII.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">RIGHT TO ATTEND SETTLEMENT HEARING</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Any DaVita stockholder may, but is not required to, appear at the Settlement Hearing via the Zoom videoconference link identified above.  If you want to be heard at the Settlement Hearing, then you must first comply with the procedures for objecting, which are set forth below.  The Court has the right to change the hearing date or time without further notice.  Thus, if you are planning to attend the Settlement Hearing, you should confirm the date and time before using the Zoom videoconference link identified above.  DaVita stockholders who have no objection to the Settlement do not need to appear at the Settlement Hearing or take any other action.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">VIII.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">RIGHT TO OBJECT TO THE PROPOSED DERIVATIVE SETTLEMENT AND PROCEDURES FOR DOING SO</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Any DaVita stockholder may appear and show cause, if he, she or it has any reason why the Settlement of the Action should not be approved as fair, reasonable and adequate, or why a judgment should not be entered thereon, or why the separately negotiated Fee and Expense Amount should not be approved.  You must object in writing, and you may request to be heard at the Settlement Hearing.  If you choose to object, then you must follow these procedures.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">19</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">A.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">You Must Make Detailed Objections in Writing</font></div></td></tr></table><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Any objections must be presented in writing and must contain the following information:</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#010000;">1.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Your name, legal address, and telephone number;</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#010000;">2.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The case name and number (</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">In re DaVita, Inc. Stockholder Derivative Litigation</font><font style="font-family:inherit;font-size:12pt;">, Civil Action No. 1:17-cv-00152-MPT);</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#010000;">3.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Proof of being a DaVita stockholder as of the Record Date;</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#010000;">4.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The date(s) you acquired your DaVita shares;</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#010000;">5.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">A statement of each objection being made;</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#010000;">6.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Notice of whether you intend to appear at the Settlement Hearing (you are not required to appear); and</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#010000;">7.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Copies of any papers you intend to submit to the Court, along with the names of any witness(es) you intend to call to testify at the Settlement Hearing and the subject(s) of their testimony.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Court may not consider any objection that does not substantially comply with these requirements.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">B.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">You Must Timely Deliver Written Objections to the Court</font></div></td></tr></table><div style="line-height:240%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">All written objections and supporting papers must be submitted to the Court either by mailing them to:</font></div><div style="line-height:120%;text-align:left;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Office of the Clerk</font></div><div style="line-height:120%;text-align:left;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">United States District Court</font></div><div style="line-height:120%;text-align:left;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">District of Delaware</font></div><div style="line-height:120%;text-align:left;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">844 North King Street, Unit 18</font></div><div style="line-height:120%;text-align:left;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Wilmington, DE 19801-3750</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">OR by filing them in person at any location of the United States District Court for the District of Delaware.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">YOUR WRITTEN OBJECTIONS MUST BE POSTMARKED OR ON FILE WITH THE CLERK OF THE COURT NO LATER THAN JANUARY 15, 2021.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Unless the Court orders otherwise, your objection will not be considered unless it is timely filed with the Court.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Any Person or entity who fails to object or otherwise request to be heard in the manner prescribed above will be deemed to have waived the right to object to any aspect of the Settlement  as incorporated in the Stipulation or otherwise request to be heard (including the right to appeal) and will be forever barred from raising such objection or request to be heard in this or any other action or proceeding, and, unless otherwise ordered by the Court, shall be bound by the Judgment to be entered and the releases to be given.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;color:#010000;font-weight:bold;">IX.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">HOW TO OBTAIN ADDITIONAL INFORMATION</font></div></td></tr></table><div style="line-height:240%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Notice summarizes the Stipulation.  It is not a complete statement of the events of the Action or the Settlement contained in the Stipulation.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">You may inspect the Stipulation and other papers in the Action at the United States District Clerk&#8217;s office at any time during regular business hours of each business day.  The Clerk&#8217;s office is located at the United States District Court for the District of Delaware, 844 North King Street, Unit 18, Wilmington, DE 19801-3750.  However, you must appear in person to inspect these documents.  The Clerk&#8217;s office will not mail copies to you.  You may also view and download the Stipulation at https://investors.davita.com.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">21</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If you have any questions about matters in this Notice you may contact by telephone at 1&#8209;800&#8209;449&#8209;4900 or in writing Rick Nelson, c/o Shareholder Relations, Robbins Geller Rudman &amp; Dowd LLP, 655 West Broadway, Suite 1900, San Diego, CA 92101.</font></div><div style="line-height:240%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">PLEASE DO NOT CALL, WRITE, OR OTHERWISE DIRECT QUESTIONS TO EITHER THE COURT OR THE CLERK&#8217;S OFFICE.</font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">DATED: ___________________, 2020</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">BY ORDER OF THE COURT</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">UNITED STATES DISTRICT COURT</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">DISTRICT OF DELAWARE</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">22</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>dva-20201106.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.davita.com/20201106" xmlns:dva="http://www.davita.com/20201106" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20201106_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20201106_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20201106_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20201106_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="DocumentAndEntityInformationDocumentAndEntityInformation" roleURI="http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation">
        <link:definition>0001000 - Document - Document and Entity Information Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>dva-20201106_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:href="dva-20201106.xsd#DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>dva-20201106_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:href="dva-20201106.xsd#DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>dva-20201106_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2_label_en-US" xlink:label="lab_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="lab_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_ED64C5DFC423E66B3F24AF64EB8E1CB9_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_ED64C5DFC423E66B3F24AF64EB8E1CB9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_ED64C5DFC423E66B3F24AF64EB8E1CB9_label_en-US" xlink:label="lab_dei_Security12bTitle_ED64C5DFC423E66B3F24AF64EB8E1CB9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_ED64C5DFC423E66B3F24AF64EB8E1CB9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_ED64C5DFC423E66B3F24AF64EB8E1CB9" xlink:to="lab_dei_Security12bTitle_ED64C5DFC423E66B3F24AF64EB8E1CB9" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_0B0E50248648802E9D82AF64EB8FC780_terseLabel_en-US" xlink:label="lab_dei_DocumentType_0B0E50248648802E9D82AF64EB8FC780" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_0B0E50248648802E9D82AF64EB8FC780_label_en-US" xlink:label="lab_dei_DocumentType_0B0E50248648802E9D82AF64EB8FC780" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_0B0E50248648802E9D82AF64EB8FC780" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_0B0E50248648802E9D82AF64EB8FC780" xlink:to="lab_dei_DocumentType_0B0E50248648802E9D82AF64EB8FC780" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_9A6FFD62359D069F4A8AAF64EB8FAB9F_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_9A6FFD62359D069F4A8AAF64EB8FAB9F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_9A6FFD62359D069F4A8AAF64EB8FAB9F_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_9A6FFD62359D069F4A8AAF64EB8FAB9F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_9A6FFD62359D069F4A8AAF64EB8FAB9F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_9A6FFD62359D069F4A8AAF64EB8FAB9F" xlink:to="lab_dei_DocumentPeriodEndDate_9A6FFD62359D069F4A8AAF64EB8FAB9F" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_1F5CF075952A9A77A030AF64EB8F424D_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_1F5CF075952A9A77A030AF64EB8F424D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_1F5CF075952A9A77A030AF64EB8F424D_label_en-US" xlink:label="lab_dei_EntityRegistrantName_1F5CF075952A9A77A030AF64EB8F424D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1F5CF075952A9A77A030AF64EB8F424D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_1F5CF075952A9A77A030AF64EB8F424D" xlink:to="lab_dei_EntityRegistrantName_1F5CF075952A9A77A030AF64EB8F424D" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_646E6C37F7BF657EB861AF64EB8F36A0_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_646E6C37F7BF657EB861AF64EB8F36A0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_646E6C37F7BF657EB861AF64EB8F36A0_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_646E6C37F7BF657EB861AF64EB8F36A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_646E6C37F7BF657EB861AF64EB8F36A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_646E6C37F7BF657EB861AF64EB8F36A0" xlink:to="lab_dei_EntityIncorporationStateCountryCode_646E6C37F7BF657EB861AF64EB8F36A0" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_9979E0521F7F88FE298EAF64EB8F6CE3_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_9979E0521F7F88FE298EAF64EB8F6CE3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_9979E0521F7F88FE298EAF64EB8F6CE3_label_en-US" xlink:label="lab_dei_EntityFileNumber_9979E0521F7F88FE298EAF64EB8F6CE3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_9979E0521F7F88FE298EAF64EB8F6CE3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_9979E0521F7F88FE298EAF64EB8F6CE3" xlink:to="lab_dei_EntityFileNumber_9979E0521F7F88FE298EAF64EB8F6CE3" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_4B034CC739E2EE2CC886AF64EB8FCB28_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_4B034CC739E2EE2CC886AF64EB8FCB28" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_4B034CC739E2EE2CC886AF64EB8FCB28_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_4B034CC739E2EE2CC886AF64EB8FCB28" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_4B034CC739E2EE2CC886AF64EB8FCB28" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_4B034CC739E2EE2CC886AF64EB8FCB28" xlink:to="lab_dei_EntityTaxIdentificationNumber_4B034CC739E2EE2CC886AF64EB8FCB28" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_11C8D1B580B0747874FEAF64EB8FC160_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_11C8D1B580B0747874FEAF64EB8FC160" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_11C8D1B580B0747874FEAF64EB8FC160_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_11C8D1B580B0747874FEAF64EB8FC160" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_11C8D1B580B0747874FEAF64EB8FC160" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_11C8D1B580B0747874FEAF64EB8FC160" xlink:to="lab_dei_EntityAddressAddressLine1_11C8D1B580B0747874FEAF64EB8FC160" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_8881449F2FC015B7F00DAF64EB902F0B_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_8881449F2FC015B7F00DAF64EB902F0B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_8881449F2FC015B7F00DAF64EB902F0B_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_8881449F2FC015B7F00DAF64EB902F0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_8881449F2FC015B7F00DAF64EB902F0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_8881449F2FC015B7F00DAF64EB902F0B" xlink:to="lab_dei_EntityAddressCityOrTown_8881449F2FC015B7F00DAF64EB902F0B" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_5F7233AA1A311F43DE0AAF64EB901D12_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_5F7233AA1A311F43DE0AAF64EB901D12" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_5F7233AA1A311F43DE0AAF64EB901D12_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_5F7233AA1A311F43DE0AAF64EB901D12" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_5F7233AA1A311F43DE0AAF64EB901D12" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_5F7233AA1A311F43DE0AAF64EB901D12" xlink:to="lab_dei_EntityAddressStateOrProvince_5F7233AA1A311F43DE0AAF64EB901D12" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_91588266EFC1214D47B5AF64EB90DFBC_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_91588266EFC1214D47B5AF64EB90DFBC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_91588266EFC1214D47B5AF64EB90DFBC_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_91588266EFC1214D47B5AF64EB90DFBC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_91588266EFC1214D47B5AF64EB90DFBC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_91588266EFC1214D47B5AF64EB90DFBC" xlink:to="lab_dei_EntityAddressPostalZipCode_91588266EFC1214D47B5AF64EB90DFBC" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_D372105883FC15C06919AF64EB90D282_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_D372105883FC15C06919AF64EB90D282" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_D372105883FC15C06919AF64EB90D282_label_en-US" xlink:label="lab_dei_CityAreaCode_D372105883FC15C06919AF64EB90D282" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_D372105883FC15C06919AF64EB90D282" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_D372105883FC15C06919AF64EB90D282" xlink:to="lab_dei_CityAreaCode_D372105883FC15C06919AF64EB90D282" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_C0CD78F00C1EC6DA6729AF64EB902E1B_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_C0CD78F00C1EC6DA6729AF64EB902E1B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_C0CD78F00C1EC6DA6729AF64EB902E1B_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_C0CD78F00C1EC6DA6729AF64EB902E1B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_C0CD78F00C1EC6DA6729AF64EB902E1B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_C0CD78F00C1EC6DA6729AF64EB902E1B" xlink:to="lab_dei_LocalPhoneNumber_C0CD78F00C1EC6DA6729AF64EB902E1B" xlink:type="arc" />
    <link:label id="lab_dei_WrittenCommunications_584C4EF542B66D2A971EAF64EB90516F_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications_584C4EF542B66D2A971EAF64EB90516F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_584C4EF542B66D2A971EAF64EB90516F_label_en-US" xlink:label="lab_dei_WrittenCommunications_584C4EF542B66D2A971EAF64EB90516F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_584C4EF542B66D2A971EAF64EB90516F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications_584C4EF542B66D2A971EAF64EB90516F" xlink:to="lab_dei_WrittenCommunications_584C4EF542B66D2A971EAF64EB90516F" xlink:type="arc" />
    <link:label id="lab_dei_SolicitingMaterial_824DF4F0B1B50D4F4277AF64EB916EA0_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial_824DF4F0B1B50D4F4277AF64EB916EA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_824DF4F0B1B50D4F4277AF64EB916EA0_label_en-US" xlink:label="lab_dei_SolicitingMaterial_824DF4F0B1B50D4F4277AF64EB916EA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_824DF4F0B1B50D4F4277AF64EB916EA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial_824DF4F0B1B50D4F4277AF64EB916EA0" xlink:to="lab_dei_SolicitingMaterial_824DF4F0B1B50D4F4277AF64EB916EA0" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementTenderOffer_BE0AD876DD598048BF47AF64EB91B72E_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_BE0AD876DD598048BF47AF64EB91B72E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_BE0AD876DD598048BF47AF64EB91B72E_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_BE0AD876DD598048BF47AF64EB91B72E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_BE0AD876DD598048BF47AF64EB91B72E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer_BE0AD876DD598048BF47AF64EB91B72E" xlink:to="lab_dei_PreCommencementTenderOffer_BE0AD876DD598048BF47AF64EB91B72E" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_65780CF8E5EAB12DEDEEAF64EB912D15_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_65780CF8E5EAB12DEDEEAF64EB912D15" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_65780CF8E5EAB12DEDEEAF64EB912D15_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_65780CF8E5EAB12DEDEEAF64EB912D15" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_65780CF8E5EAB12DEDEEAF64EB912D15" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer_65780CF8E5EAB12DEDEEAF64EB912D15" xlink:to="lab_dei_PreCommencementIssuerTenderOffer_65780CF8E5EAB12DEDEEAF64EB912D15" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_CEEB2F8D9D0DDFDAA04FAF64EB9185CF_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_CEEB2F8D9D0DDFDAA04FAF64EB9185CF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_CEEB2F8D9D0DDFDAA04FAF64EB9185CF_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_CEEB2F8D9D0DDFDAA04FAF64EB9185CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_CEEB2F8D9D0DDFDAA04FAF64EB9185CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_CEEB2F8D9D0DDFDAA04FAF64EB9185CF" xlink:to="lab_dei_EntityEmergingGrowthCompany_CEEB2F8D9D0DDFDAA04FAF64EB9185CF" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_ED86DD026A7A16FCA543AF64EB918693_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_ED86DD026A7A16FCA543AF64EB918693" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_ED86DD026A7A16FCA543AF64EB918693_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_ED86DD026A7A16FCA543AF64EB918693" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_ED86DD026A7A16FCA543AF64EB918693" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_ED86DD026A7A16FCA543AF64EB918693" xlink:to="lab_dei_EntityCentralIndexKey_ED86DD026A7A16FCA543AF64EB918693" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_32328427318E44D5A835AF64EB91B8E9_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_32328427318E44D5A835AF64EB91B8E9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_32328427318E44D5A835AF64EB91B8E9_label_en-US" xlink:label="lab_dei_AmendmentFlag_32328427318E44D5A835AF64EB91B8E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_32328427318E44D5A835AF64EB91B8E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_32328427318E44D5A835AF64EB91B8E9" xlink:to="lab_dei_AmendmentFlag_32328427318E44D5A835AF64EB91B8E9" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_4EA63A8BD01B00E3130BAF64EB927DE3_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_4EA63A8BD01B00E3130BAF64EB927DE3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_4EA63A8BD01B00E3130BAF64EB927DE3_label_en-US" xlink:label="lab_dei_TradingSymbol_4EA63A8BD01B00E3130BAF64EB927DE3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_4EA63A8BD01B00E3130BAF64EB927DE3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_4EA63A8BD01B00E3130BAF64EB927DE3" xlink:to="lab_dei_TradingSymbol_4EA63A8BD01B00E3130BAF64EB927DE3" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_71DAE6991FE327412B60AF64EB922F46_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_71DAE6991FE327412B60AF64EB922F46" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_71DAE6991FE327412B60AF64EB922F46_label_en-US" xlink:label="lab_dei_SecurityExchangeName_71DAE6991FE327412B60AF64EB922F46" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_71DAE6991FE327412B60AF64EB922F46" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_71DAE6991FE327412B60AF64EB922F46" xlink:to="lab_dei_SecurityExchangeName_71DAE6991FE327412B60AF64EB922F46" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>dva-20201106_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:href="dva-20201106.xsd#DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_ED64C5DFC423E66B3F24AF64EB8E1CB9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_Security12bTitle_ED64C5DFC423E66B3F24AF64EB8E1CB9" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_0B0E50248648802E9D82AF64EB8FC780" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_DocumentType_0B0E50248648802E9D82AF64EB8FC780" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_9A6FFD62359D069F4A8AAF64EB8FAB9F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_DocumentPeriodEndDate_9A6FFD62359D069F4A8AAF64EB8FAB9F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1F5CF075952A9A77A030AF64EB8F424D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_EntityRegistrantName_1F5CF075952A9A77A030AF64EB8F424D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_646E6C37F7BF657EB861AF64EB8F36A0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_646E6C37F7BF657EB861AF64EB8F36A0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_9979E0521F7F88FE298EAF64EB8F6CE3" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_EntityFileNumber_9979E0521F7F88FE298EAF64EB8F6CE3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_4B034CC739E2EE2CC886AF64EB8FCB28" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_EntityTaxIdentificationNumber_4B034CC739E2EE2CC886AF64EB8FCB28" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_11C8D1B580B0747874FEAF64EB8FC160" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_EntityAddressAddressLine1_11C8D1B580B0747874FEAF64EB8FC160" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_8881449F2FC015B7F00DAF64EB902F0B" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_EntityAddressCityOrTown_8881449F2FC015B7F00DAF64EB902F0B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_5F7233AA1A311F43DE0AAF64EB901D12" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_EntityAddressStateOrProvince_5F7233AA1A311F43DE0AAF64EB901D12" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_91588266EFC1214D47B5AF64EB90DFBC" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_EntityAddressPostalZipCode_91588266EFC1214D47B5AF64EB90DFBC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_D372105883FC15C06919AF64EB90D282" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_CityAreaCode_D372105883FC15C06919AF64EB90D282" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_C0CD78F00C1EC6DA6729AF64EB902E1B" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_LocalPhoneNumber_C0CD78F00C1EC6DA6729AF64EB902E1B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_584C4EF542B66D2A971EAF64EB90516F" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_WrittenCommunications_584C4EF542B66D2A971EAF64EB90516F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_824DF4F0B1B50D4F4277AF64EB916EA0" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_SolicitingMaterial_824DF4F0B1B50D4F4277AF64EB916EA0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_BE0AD876DD598048BF47AF64EB91B72E" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_PreCommencementTenderOffer_BE0AD876DD598048BF47AF64EB91B72E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_65780CF8E5EAB12DEDEEAF64EB912D15" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_65780CF8E5EAB12DEDEEAF64EB912D15" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_CEEB2F8D9D0DDFDAA04FAF64EB9185CF" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_EntityEmergingGrowthCompany_CEEB2F8D9D0DDFDAA04FAF64EB9185CF" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_ED86DD026A7A16FCA543AF64EB918693" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_EntityCentralIndexKey_ED86DD026A7A16FCA543AF64EB918693" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_32328427318E44D5A835AF64EB91B8E9" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_AmendmentFlag_32328427318E44D5A835AF64EB91B8E9" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_4EA63A8BD01B00E3130BAF64EB927DE3" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_TradingSymbol_4EA63A8BD01B00E3130BAF64EB927DE3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_71DAE6991FE327412B60AF64EB922F46" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0E4E8ABEB3DB4DC3C788AF64EB8ECCD2" xlink:to="loc_dei_SecurityExchangeName_71DAE6991FE327412B60AF64EB922F46" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>formresettlementderiva_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="dva-20201106.xsd" xlink:type="simple"/>
    <context id="D2020Q4Settlement">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2020-11-06</startDate>
            <endDate>2020-11-06</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="D2020Q4Settlement"
      id="Fact-BA41EB73F33DA7178E7AAF64EB617CAE-wk-Fact-BA41EB73F33DA7178E7AAF64EB617CAE">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="D2020Q4Settlement"
      id="Fact-41A3CD831491C17AF572AF64EB5F9A0F-wk-Fact-41A3CD831491C17AF572AF64EB5F9A0F">0000927066</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="D2020Q4Settlement"
      id="d52252e97-wk-Fact-5E0B1C6A6861392752FBAF64EB680275">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="D2020Q4Settlement"
      id="d52252e124-wk-Fact-AB2B5AF73D8902B67BE8AF64EB6722C9">2020-11-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="D2020Q4Settlement"
      id="d52252e137-wk-Fact-AE5A41C0039D9BACD02CAF64EB63CFE1">DAVITA INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="D2020Q4Settlement"
      id="d52252e166-wk-Fact-176130BBF864BF4514F5AF64EB6F2870">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="D2020Q4Settlement"
      id="d52252e171-wk-Fact-FA4C98DD8A69294E29D6AF64EB60706B">1-14106</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="D2020Q4Settlement"
      id="d52252e176-wk-Fact-B0E7B8617CCAC724532CAF64EB6D728B">51-0354549</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="D2020Q4Settlement"
      id="d52252e216-wk-Fact-7118C4961F92B2591DABAF64EB6D9FE4">2000 16th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="D2020Q4Settlement"
      id="d52252e232-wk-Fact-E20449539E45A7F1D89BAF64EB630386">Denver,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="D2020Q4Settlement"
      id="d52252e237-wk-Fact-DC1AF8001993382D07C7AF64EB5EF4FE">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="D2020Q4Settlement"
      id="d52252e242-wk-Fact-98CDAC3013CA9592B732AF64EB619F7B">80202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="D2020Q4Settlement"
      id="d52252e254-wk-Fact-6D530121D2ADA6B76AB5AF64EB5F4BCF">720</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="D2020Q4Settlement"
      id="d52252e259-wk-Fact-DA2BC3ED2C467412CD7AAF64EB6AC5F3">631-2100 </dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="D2020Q4Settlement"
      id="d52252e285-wk-Fact-F273D264E6B0D8CF4FFAAF64EB616C33">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="D2020Q4Settlement"
      id="d52252e296-wk-Fact-60FB6850298D753F2E04AF64EB6C459B">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="D2020Q4Settlement"
      id="d52252e306-wk-Fact-D58EBE4872B6E72CB504AF64EB65C0BA">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="D2020Q4Settlement"
      id="d52252e316-wk-Fact-A5E8F6AA722C542227FAAF64EB6688F3">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="D2020Q4Settlement"
      id="d52252e367-wk-Fact-AC75842858E7125CE313AF64EB6A9C86">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="D2020Q4Settlement"
      id="d52252e377-wk-Fact-358F54F98F29E8C46493AF64EB695A45">DVA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="D2020Q4Settlement"
      id="d52252e387-wk-Fact-932A0BD7D4D0099DB33CAF64EB6BAB28">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="D2020Q4Settlement"
      id="d52252e393-wk-Fact-491764557AC0563585C4AF64EB6E3022">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139892517997928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document and Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 06, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  06,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DAVITA INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-14106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0354549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2000 16th Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Denver,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">631-2100 <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000927066<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DVA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MJJN2ZNH<JJF,E,Z4+A92"Z($QHPH3<8JEU:_PS6N1<7%)_<(X75)>'T.X8.
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MZ*%K66\=\+H/@Y1DZ>ETSQ07FA:9'M2#PIY49M"8TQ-E1=88O3.O:21\*5=
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M,:@W6]5C6)>E:H\_A?<HN9\;[O\2Q0]02P,$%     @  H)M49>*NQS
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M=1,92L88!.R '<(Y_<Z[5ITPX1X=\G>A^[<#K3P&]'@!6^A<JU3'\TLDO,3
MQFU+BLX5>C(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=
MR_$)'0.M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D
M&IND53 >"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&
ML&]R( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @
M H)M420>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_O
MR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!
MV#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6
MHJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0
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M&G_FB^$_7G\!4$L! A0#%     @  H)M40=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  "@FU1/-2+
M4NT    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    "  "@FU1F5R<(Q &  "<)P  $P              @ '+ 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (  *";5$^CUG40 0  &,0
M   8              " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    "  "@FU1@ZFE ]0!   R!@  #0              @ &"#
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    (  *";5&7BKL<P    !,"   +
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4!08     "0 ) #X"   %$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="formresettlementderiva.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Document and Entity Information Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="formresettlementderiva.htm">formresettlementderiva.htm</File>
    <File>dva-20201106.xsd</File>
    <File>dva-20201106_cal.xml</File>
    <File>dva-20201106_def.xml</File>
    <File>dva-20201106_lab.xml</File>
    <File>dva-20201106_pre.xml</File>
    <File>ex991-stipulationofset.htm</File>
    <File>ex992-noticeofproposed.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "formresettlementderiva.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "dva-20201106_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dva-20201106_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "formresettlementderiva.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dva-20201106_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dva-20201106_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "dva-20201106.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "dva",
   "nsuri": "http://www.davita.com/20201106",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "formresettlementderiva.htm",
      "contextRef": "D2020Q4Settlement",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:Security12bTitle",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Document and Entity Information Document and Entity Information",
     "role": "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation",
     "shortName": "Document and Entity Information Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "formresettlementderiva.htm",
      "contextRef": "D2020Q4Settlement",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:Security12bTitle",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000927066-20-000219-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000927066-20-000219-xbrl.zip
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M=<TV)+0^BQ.90FL"LL#3^@@KE2VUAF"(8OGA''E?E1=;3P])L;$+ZD XC2G
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MOB_$1<@>X<9*<;!N_6O<*2LJW= 6BZF_L9H6%94U-Z_)U_3AR3]02P,$%
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M%^+^X'06VOTT7')_^L9NNE-[KG^].+8X4%N0#%@ ZI*3V[S?^ !02P,$%
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ME\".^$OT(F.*71FS\4+8 #$HQ()( B5 I =Q#[WA/#':#/92."JM[+6#PA8
MB4_)?H:_4U1P [VJ8% B#PUQ[7-* PJN)S!XIUVJ.>=P7Y0)!3*_U(MT8S*6
M15T 5G3BHH[60>7T34&6/TJR1TF&DNQ>BC(L5B<I=7#T7NSWW_6/]GM'YV?&
MB;'?/SKH'9(L^W9Z?/1^_QBO0S%W>-#;/3@\./_]'DBV\P5\GKBSSHK3P!,D
M3R@33@'SU=XU4(MUA,J6'1@&I>]"X8"N,BZB([@-KSBYSKWZ6LE>)'\>EI-G
MY]')\Q;T%PR'@N">$$!*@^1R2W/:@D)28G)R):4C";([$)=9FHS#E,J:745?
MFHE03BE:>0FR+4^19H'8V@C,O0X]DF2A1Z]T+JSLQ1<"^1J%3BISXK<I[N1B
M^MJ8BZ_-V%!%MSPJ @,2Y51>FF:V;J=RDXG>!Y3L3+(:$:J&*'LSD6+&JG_Z
M H8MDACU+^.0IS-0H(/9"^HG\EM43/"%XF@:N;2U-%-C7N9%)_4Z#A)HD"VN
MW2\P22 /K.XQ-W7'H=9CZJ7'.!%:!KJ=D #22UX=K7' !76%PTW?;6E@P9Y:
M;J"Z+9VL.==$A-=AGBS,,)OB+SDEVN= @$8S-06JAN=5C0#<&'SKRRA7-F"U
M8 %M";(CN>I2\@^Z-)F>B(0"6A^JTJAN!'H!S3M=LM=BAH,F]&JD*T?D R6'
M/AVO&7PU)-V'7!RY.6A8HT  :)[-HRZB$)-$8%\O5 Q#<Y$<^E=UW4&N7\+5
M!=A]ED.MQ8ZQ$G<DZ0T2'2<")2GA$M\Y!G3R-(%7FIN'ASH'[E=T3VU1:$U7
M[TS$$1TD=V.D'20VW!6T;M,4"4E&_I2<E9=F6$3L*_&TNH8#M)*'?3&'-T8)
MQNI'E-,!= 7V8^>]GAGO-9$F!L 0:XHJ#KN8DGX$"@/,.0:VN)B%7&LG:MLW
M< :C+HI",[%JO-W48*0$22P-KW)!RDY"KG<MP[/IF+2'$1:!4,D^Q]GYZ"2T
M-6 RUP@PL.*MK@)YD&8Z-WE68N#="@5\/S01!XI1RQBL3 .7<4#-$IH^517L
M@E:,L2NM/EB5=[I84%ZD46B"GV%:#HKVLX*V,.E=[/KDG*6J*9FG,=828;X7
M2IQ$:O^$M\,PR3(+56)D*[D_4 ?0O!*! C)F*Q5K_:3,\E(F-5@U-T<"90N:
MK[3"X4=R\KJMT:T5&(BM2%<1PP!^A85*4E2*T;'.-;M%5K*80#T$0]&&;UF^
M26(#^(P6UX(1"(8Z)JYW"/,!C("!_SPL3?CYHR;\=A%C(:&LL46-]D<2Q.A
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MPW)QT:GB[%_Z)AT.RRSKHD]K<_TVN01+Y$COT-)M;B"&)F'?%"M%'PUJ+Z8
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MDUL206S_76(A'+Z"]V)V*N9A-]64&5Z1.HS=!J.KZG#2F.GPSZ^GS8],YN"
MC.LQ-;+A_*!BDD3#IQGP#AFCR8W8EL6\ZL 8P7KD.K5Q9^.?I# G+EFWN$RI
M^QC?DZO6M?0\([ #! UI$ZSPE8  9@'GKPSF'!ME-BP;7I59:I N\N9 J9=U
M*+"AKT<C(V<?ZUR)NH'<%H!X5)E_@O^&]X3_4N:8(0TC[WVZ+0=TJ$/O4!,R
MQDUY@>5N#!CB#8TI.N@!@H$OO6(_?=2\I)M*,SNJAN73I(>>-T^@]Q2OJK9M
M+O1GM5N>%C#T'C5XSX9.]1/^ VOZFE-<7_4'K^O?!O[K0>GZ3J_0IJG5:G[.
M1 5-_TS7@(&-S@[5]4<]^6?XM+H??/J8=-LJ:T:A[NF.FH)NP(D:.4R5;*-6
MVY'&,K2VM3):#8SGGQT6]K40C@@&,=YW8J\JUC=6.#RV%0 YDJ05_Z$A^ZE2
M')H $82(N:77<C6!)1:O-BA3KYF/14^KKI5^J1':$LYPQ3:_"26AE;"&L>XK
MZY[+">6F<ZL_%L(24US*A!@JLQQ4?)%U6,M'5>IGC^CH?AS1 R9.@MWVB)*/
MB0ZB)JDC)" 2@C6O$!)Z2&P\RG?Y ^G;"%DN5N3J&G9()HX?5.[PLOAGRA(G
MP2T89Z3-7<G1V#1=/?%T*#\RQO@3C3SD1P+^60(>WQ,"'GFN B^86N':SD/Q
M<T1:;9A.!*.]%*IBJ@:UD4U)$P_23MR<BFW8+X7;X?=8<FV@\WX\TO'MZ'AR
M/^@8PT S ^VBD;1<?HU)_B!0(2)I+#-2^81HQ1!>K8= /6F!O)(Z(<2F^AI,
MIU$UX1S3.UQ>1/4TA:6U_DRJ"+G^>K8@CLI+O/*4H.+\-"G\H3.!KWK<+(L<
M?F,](HM@]S(69QZ8TV>C#%%^R,[Z34S4G]GL!2:63NQ:6UZ.\KTWI6^#A-RY
M-,6EI21O+\Q1W#OL?=OM[7T2)\>'!WN_=RX9<2^6EQB*P$A<6&(?D@B-./1-
M3Z,<I%N:61,/4X&I:C7!8%LT19^"TAEYA1IGVHWM1K"W^W[F"?X((_II%!<R
M+I5.9:NR'%O+@" Q\*YKE)1!53US5G5U5G)>+>6Y71584X[=P5*#FK*(2GH.
MXE#G/QIN;58#>*E.PK&K8*JT,$<ZP?#0&KL0$890);GV^V!9^0)&O-<_Q@2V
MO7?'1K:P34&*C0,NX-)@?*%,V=8]B])MW.:[+C\@?6R\S Z;I F^:!R9K(9&
MK(T:+C5IR22(TEM4.EZ90C"&=\Q=?QA,JS6YFUR<S)8(".JTG*EZEAZ'Q/1V
MN#";2R+5<7/U@T4X#TD9FC?8";+^=2]$7RZ#/%VC1*09+% :4NV/JO;6T2%R
M4^76LM:5+<*"3^Z[!._B8R?MH:^&03SA23:SS/B>91[9T(_*,GBQM,RU6N#E
M7=UPWI7Y7KH&6S:QREN#ZHO!=>P3\:F 7X)23S&\JC**^R-MJ/!-!P_]X$:'
M7I;%),VB/ZMY<P2CJ+)AE"O:23"3M7?K5KS ZZA</[Y'_>/\D1E<PPRP$!//
MOFZO=7=LX('ICK?IV= )I("E<(06/G?_&>_MJFR6PWF'O\1Y/87K+^:]MOTY
M)N+DRGE/$7&N B:-7C-R#V#WZ 1-[8N(.P/F%*=9!"=ENWC;L,N*K.L$??T6
M=31%*PV0(S)HL(5B=':!^(RPN92/9)9EQ8# D'/!LGQN,FC\:$ZIT2B]GJUA
MMT1K_0-=M%%_8S8'*H2><!K*))J:5X8W =*+2'TB=S7\C]P1@S0I:6*N2M)N
M:&TKLW2<R:F0E$Q RR,+^RVI<&GF0PG[/^6KZ^*\6?PBF[,AN Z_/*=&G:Y+
M:91<<-JC[E+:OA_!@E6S"B[67D7Y=]P/EH5&M.,B,<NIDF$Y8Q&)GB^N0:N2
MAU[9!<M(RV^473H2;AS;#-.TE,2_VZ?UACQ7'60_X6+V@Z@OM* YV;0JU%:M
MIWC4W=O#U1;/-/(4C?7EUZKI@BU3[Z>)2*=@(;41(7A[3!#.I$=Q'-(^(U$6
MIJ9,@ .66<(>=?GCMFWTEK+HK0ZX+A:U/EOH,#HZ/EK334*^]L7>A][!*?8-
MP0)WKFWMG OI';='TCBB6&E:.\3-?K#6[1PT*^8\?'TICM)DK<^W7^A**M3=
M4\[CFA 6:[AP$-,N5GKR_H'IV+?IY-4)'?L."'"!MG,=;! GE&C&QW'S )C>
M.$H(((\JA1/%IW(S,(6K]8(^G]Y0B":M=;K:X+0J'<(W>(5#&MJ'$D$8%U%9
MHM<:O)\[SB^!3>7=V= MA5T#C.Y!N+3A:#Y"N=P1E,O.$J%<EBD).2XBCH\H
M0G)^L-<[)""'P^/=W=^Q3U;_7R?]H_V#\R^G_;.[C@LN!=YAH6AO1C=F)=?P
M8BK<"5LWIZZG/7Y#FT9*V6$Z&,SQ]!/.9A@5%# VI;E\MS':JN5]?M=TAW7F
MFBH1#N>%43SM0V/]P Z&4C9_I=QCB<"^#<TEI;(.S'E:B,6C=U/YNXF:%%;Z
M1 S-QINH:RITC4^>QH1]2JVITFEJ"T&=W4H5GQFZ;0)0CRZB+$T(#0S3+].A
M :/VLGP-UFM>=[UJ'VKU096K4=V;@6EA*TR]VP/=P O((7>](XCFA\:8'Z<R
MKC^V@V[\K0X1W&?C0N$F1\HNWXD7%46B,=XYXVYG-8@LOMYH!-H'*#U*DFM$
MNY% 7(+&IQN)6C.S,D@38:6#V[7=H>VZ&7_@O?.5/,LA<F(07&(7880O-E4M
M2SKV <FCRJFN8^9W<,^?=6C/#UNYNZ1^ *&J-Q^SW4:HIR+LDY/!,UMPVN#-
MUD*H-!:FCKT.^XCYMS8A;NFQ68:RM'LK9>GGU1RC6KD5]G?H4=.Y'LQFD1Y#
MB8RMJTIT/TJ'I:YONS.UY6&Y<K8V[KLK9RD'X(YT4T\7?51%E\$11)BJG!Q9
M!"! L'=8\ HG6GFA30.7WR+KZI900;#Z"4:9@0E$DOKT2LZ]E]BR,B^J,5-X
M!7R!#NY9U_31.A=WFV"5S2C_>W65#NYBES3,1R/PVB7:Z=!V_:H1V'(P_QXK
M,&AOG=8Y@V+O9PP*#=>F9(Z"A;+X#$PG:0;8T_M"1C%%)_QJ^L'<-]2CY#LU
M:<'5N52#/"I:6DM0.R0Z+?'<_%H!_L$\0Y1NL-FK'31$GG?H-.E0K_./ZXY[
M30C-?7G2VW->\3#*!P@6R9FHSKUJ^9O.Q'NG<TC[IM:/1B;X8RLS]4YWD/&]
MZ-!6O7/9N-RLQEF,O.@-P+4NK.#+#JU@S^7&<2YSC AE8BB!E:$UPSF:AH8[
MR)+WKV3)HQ(XL:[(S23!\% U(QQOMLZT0N.!2C#W)NFIZD8<51YRHC<9?.%%
M.I3PO1IA665%_33N(-_N6!<=[(;5_QF9EN8%ER7#=$4Y"VF*P/&B-4['BZ\L
MF[*,\Y0&,)RS*8_NMZOE-AW6'ZZKY56'N-XA*54_I319G<L3.<PQ=164;J(P
MM>7^%G:4LUNI U<T* O.MS5-YS6J!>:P8H'C9:([Z,T4HZBZ2RFO$MZ)M([5
MJI]9%XH'/K .CD(<C\:&7SNH3&QN=(HJ<FLL%>F,>ZP5&?HI9$[FC6T$>CE)
MIV9?9MAICUHR!LCM8]T"E?A@I?&=1P)L"K0,3?B($NEAC$T@HL3S@=O8O5$D
MZXZ6@0(N/>(N!HSGW/1#WM0@0[-]R@!-1.F5CM;G-UDA5'\OE3=I5(9?BW7\
M?YKU=Y$BNQ03Z25,4:XM$^X8\/Y<I[C7FL':M;8-]JKFN^U7Z!!)- B_LU;R
M<J;-%5T5@!M=J*0VN ?9Y>&W]5<V5P/G D?C]2?9K S_D$,/J-6;?Q>II4O^
M\IZ8P IH#9YW>&;HID8H+E4T$=_5O$6_Q1H0%<],6TO=/(=U6G,W!]],C0#"
MUPQ!;BU*2K)E05XW^0'V@+XJ"--P"HF5VV#QTN6O(_3X#V'%U/KX5Z%]+9(O
M,?CC,O.2KM@:8&0[F%L2DF\S0$T 4W^U&0*7 I_E1:8NGZ6IPFYSH%=WIX[%
MK*PVDJF$D']S['TM5OIGI_NK\&4TM:X)D%)4I!3%J''89AZXV(DJ+M/L.QQ"
M]>\2#!O#IU=O=_264A=P([.%7,QDM7C>:YPI6R!4TT0(IK-H6&(Y).$M5=L.
MK0]!UAO/&T'D.8^>7L7NF<6/#2V7D 7]_)YF0=M6=@='^WW,=\:6E?<@V;D>
MU_!ED0^6O ;,- M!-#Q_OO[\Q3\-='E[^S9;3*%9MU=088I*;=B0,*M,A:E!
M)@6B_QV9)$%,B?Z/(?75]+$"\K:NY_?;I[%UWWT:=T&.*;=P@#T.*W4XNC)V
MB+6KH>0*-1W+1H"',L/N.X$/2S@MT9$6YZG >M5\-*\YRJB/-U!K%Y/&KD :
MP@-KYTA0B06']K"A'Y<AJ<17&&-;U;?R;+6Z@!04M"D8==40G1L)?4MQ,5 .
MX_D:>T^P-CH*(YE9-VUBS_J4^[7 4M,D-8>PQ>3>:8<7//K]K"_0*:!"^]S/
MDN'EM+VSO;'=6]^PS1+N>O+U,BU1?<'3$B3Z]F#MA7F\948]K,A><1/W?VB6
M=3F,GJZG)UT!>+/O\":&)391+VH'4GO:C(/'-@VQ1!'//5BD^G94=K>RHU0H
M7:N@GW(K(-B _P)^'FQL;'!WO%J%.K4W&:+?SA@%LOJ#0QFH=$#IXLXL!L1H
MX0KF7/.\$G$U?7*5."^1]F8-#1](-)[%P"2-^#D_\Q;3UQ#'U8_,&=3U7E2A
M=T&S7PH([+6:_2^"P+:HR-M+5.V7!@QYIHI"XQ>>6)37>Z#7;Z_?)D1VUUXS
MZAW31!$X*R+3ER@0ATJ&KJN%MB&X$0NCA[B+19&.%;$J<M*@>M+_,8D&^(>%
M2BRSPL/",/UC,%*3S34H2IHAWA@J,Z +%A'%5K7B@+Y3O$J/*WJ"0<XK,'PG
MF8HC1.: $7O8+.P"])9C'-1EK*#-@I@]B*'9YIRB\($WCC3C&- 41X .6UB_
M9&7]=%]COMED>>K>Y)3;3UR]XN7VQCY*X?"I8/%B *\O"DQ4#,U*2&_5>VN;
MKNLM#645'GQV;VW+_GQ63J<XT<IE;]CNHZ\XU:1R%<BB..86:O&<U\R,5I_"
M]16T8Y50>!'=]=9P?6"VY/:C+?GVAB?'QG J4$7NW@^@G.JT31?2H<YNW7-)
M;J_?QHEPQUS_&YMA%,!<V5EUP0GLQF(6.LH1,0E.N-7ND6\S>R9.ZC%'M":9
MPQDKQ&U38$/X$VZ:6.:J=:<U0]&=+,HLB?*)RXL^<S"3>+%58%WZ(#7>D.(=
MRH>7:Y^"6FT;#5+E72-M2,.TD?SN,+9RD%R :$E=+YQ=L\3[$H;ZY9T+/,%I
M/?L+%A(^U;1_X\>7A9@4Q2Q__?1I9%YT/907VM__E+,MR-.(!7YD3^AMT,R]
M,C_T'N2N<P->II\4Z+8\5K13!FB$09JJ5 X,'+\,D9; R >1*29SQ$+$,*IM
M7(DS:T6SGLFY;@F'\6$V"F"!<FI01"%^;OAY$>D,-7M9HI>KSE^"BL;!Y.W#
MQ<%QZ"*?N8V N>N<DJKB2%M,?C^M>C&)(?N?KS$S>K;C^8*(&Y$8:]>)- HS
M9N!1YYW XU,8,$4*TB)BI5TQT1+$:D1 9J:C'YTDBQ((*HO2RF$[ 5M9]=%V
M:KY"87/J:RYVZ=8]K;L%7DLATE=4^!IAZFKLM:(A>1,"48B%)X%/WYRLB3'-
M0A&D'S6:@X4CO@D#DJH.S/R/,HQTVDRO6@MFGX*7[ZL1[D_2Q838[?5GW2'_
M$UU60LY)"G(CC>]+Y(NZ2 *1CM':8&I#Y$4PMBVQZ%UP/7P+.:>LVJ&:T5Z3
MP7*).*JV"2&GM 26'NVVG>AV*@X6"TP0JB3$-LAH '))(!M!^M'\JWU+RH&@
M*3$_'L+91OL#SB ES53>NWO4\>@]6H;WZ-E]]!Z=*@R@W@N'T;,N.8R^S'1Z
M2)VAL:H9""R9;'$\5[*8#&^JZ0<KF ?'\( %]4A/+Q.3ULG2.(LN)+L:\"+]
MDWW8:D :X#A--=9JB>[L2''^L=]^F!,)ARJ:%9YX')**RLX)ZAU);57D\'N2
M7L8J'*.&P=SS@?DD;B,S'XI/P@6W-0 TBU @ ,Y&U\8-8FC753VO\#2@HALP
M-K!TB/[ BX$JU04UP<;&/J!V$261UH:E.<R*Z*^<T*;INRCY=TD6,-A&DD#E
MK9(PD=E8XPEK-4Z%=2V.SB%>H4BCT/P.%$T4V6+%U>I\29"^$_XA7ZWH?/:N
M$ZI)[Z#"]ZQ+?I6%S-$PQ;8UM>1DX E/3#G#7\3,;DCYOT3Q/FT[BJX3LJ55
M*CX;>1VTZ=MF0VVP\9)<Q?8>$]8TGJ9*RJR&]8N,5!E*5.V*.9>3-&Y8971E
M&I;5VZL.2Q:1"84P#NDH\!7D )5GBGLGB7:.V-1P/&!14?+^&?6;8P6D2M.?
MN3/KR*\!\RC]S7 J>H6L^-76!1K)&,DP2>[&W4Y*_J6D+F,$MDMC%UFD.RYG
M>(9S@TU>,1^X=0-FKVLSL6J&.C=4]_C$H^J_#-5_F<BX2U/]JUJGAVE-/,5^
M/E/8*( 28X[4."TB8LX]V/\L47/+BMXIZY'&])9[85'L=,FBX!!THI?8^$MF
M&3#=:%8/!OK>V:$6 B@F:Y8$[H<Q2+11,9AK0<N]C]'SI@?P2G: ^T;HLV-W
M,$H[)4XF41Q'LQP9LJ6(Q%$$W5>GBI&A"J6IHI(@Q8U4T&.-4,0+I1OWNM$J
MA>=-!(F=J!'/(!FI##.DRIEU]QL/M5LK$ 8'B8A]/)1KAH,A%KZ7ZZIC"K^O
M7^HFJDU >634VY=A V$U_FMS![/%3,;8]:M*3M8_=!F(3BPP;EG?Y0N'U#^C
MHD=5J<;MJ^,)#4^9IRRQIJ$;$6,"-NQB^Z!^C@.V4LC;]_B!69 [CQ;D6W-L
MK59-N9$&5-IT[/#3EN2<.1F?%B"K1*?UZH.<>H&/JN?=T_I\FZ'2X0-#8YIC
M4;446@VZ[@E=O&J$O1,ZIZCM=,Z@(\/&\14__L?&UP)&4*4#2P#]?)BEEZ"]
M#TV'Q--T, "+0+P'W1-$X6D93C%Y64YG;\1^>AF*P\,3*L;@]G*4\C!& D+)
MMY!-!R;;VH;YVP)KUT9F:_--T@*'I11](ZO5#TP3UT*36FB!-DQ1W!CE%S%H
M7>"M8UP85DBQ15>D,Z)@=17*>J)+6*F $0YCI&X"', ,I^]&%IY5+"/J7P;T
MSW>C%>8)A>NE6(Z&*F9U#8"V31(;(RG2GH,FPB>(JMS97)KQR<U%-.+3>SE1
M2:7'NUD*/3&-P#>"-:0\7B^F0GV)I]0CGGJ;46D=V-3-Z0=7I:!13[,DT@ *
MJ'F7(#M#M -51 _53"4QJ>#T9<,;4>,@;E6:=9?7KZT1V#AWJPD-U#S5+H\%
M)\?/#UO$1ZO'J'L&YTZ7 O$M)+!(L-3VOR8XL(E?)/6'2Q!9>4I^GCIID%(<
MQVDUJW&!0H=JD@D>$C9F@9R)4S*O8&\5.H;= \X88GE*FAE $>U,07[);@U\
M-6S.=J$TVTBS&[\?G"3L+A=&^:PD?H"@G9S".:_-E6[S2?Z:N?B+GJ2Z(+K)
M[+I'Y(]>E65X5999:;LTK\I>BD!?)"?@!#BB?:.=X6S\Y4:"!6(/S>S8-"K-
MQ+EKI7@/7"C/N^1".6^$')SP')I]<:Z$=,C^<JVPQ5:=<"68U)*VI?[R?ENI
MS^^[E>I3\JOG=U;1VAU*+B:U;I.^RX@]1B8/LY[YEH0VS$;5)N@VK'?V:_?@
MM6NA=X?Z<6<[->C83NE42YF;5,6KTR-_.36R5M]"28S=VYUAQW;'!FMQ@P:@
M]4[UWG1/CWS>):?/P<@OE1XZO0:M&POZ!0]YN?4&U !".L)TRJEB?U"SCJ6B
M$'FBF30@'0XWG:2YAO\/SX[RVNS 0/Q<\_0MNO?Y^C9FVL=87^!'15KS/Z=E
MP5BE[,Y&^#.LJ^"D3NV88'L.?1F)NL3HO8P+!#5'_8(,KVD:\DK4:P]T66#$
MSJFJ2Q[#$"/=&WYN@-R:Z1*NW04I*AQ';]8EHL?#+1I?E>LUC?47+C]V)*,X
MY]H2.@C*/K+Z/K>#G'CP\KDM3A*TI[2TNZ:IXP%6CMC*GB@SC@/<#8>N1@YQ
M=BV&-9@";*4 -W\LX=/F#O4/KK>][<+&=4E<]S#GV\1887D#WP<9P)$;ENS1
MG*%WTW:K1U0U_IXZEK2FL]2.I=UGT][$JRQ(6UE2X.6DNV0D<@ G>9&53"K<
M 5J&IMH+HXSU]!3C=$4 $'8C!3J%W6+^N?HI_3CJG:738J82)I=9EJ#!:\2*
M!U#1F@&##EP&/H6!F+6LFC%1U\%REZ3PEKR6X<^90LZ;)5NR[Q^UGAMQ)]X0
M*JNNR,U&5;8-^G,YA><&K-ZH)>Z.EK5.\M:\=L:WS[1!Y@@[/MI\H\U8\R*R
MO()*/'*J4:RN.8<O_C!*($K#C!+BC*Y>J>O$@8=#N(*2'^S:+$KP<J>\ +E9
M,)3)A1RR*+[#0LJD3(8X45' '[],&$V-]WX[,EX\.C):6%'8,594#1]:%8<A
MT=NJ]W1"@-_'2Z/#ZMAFXFM1'.!S45[8*K ]5C8;!=T&3%@CH7M8QJZ2J_D6
M7;02NQ122S5(B84-H_)X8QH-K5^;$J%SC$LE)AJLU926^V%KAF!HU=#S\?JV
MT%1@2IQ=H(G0A37-F,!:A='#?E^= &GJ]%.=HZS$.$LI](U"9ECSVA?.:]\J
M927+0*8_$HTF>MAV-0P8@MDP9\U'.600Z\N@^"_9<+A&'75G/(;%EA$6>W$?
MPV*?HYS.2Z(08/G$:I;W(,3UHFLAKH;23'7Q7I(F=]^A7!AV+!  >6'*^DOJ
MZ>#IM<@MAY6X9=V:=?7R.OD31]+M21Q(/SW$5MQC; %S>!!HI$A]>'/BSM.9
MB5C$\17OT8*$DR)05S:,&#\%ID< \@9P'7&?AEAA9M%.L AGG)(LN=ECNL=)
M7W3),=Q*@XQQKPG'*5':86&2!VGE<>=9%?0J>9 *:K4[<&=QB;I<,V'$);:W
M]@<(;(@W46"88DZ95UU6\=&Y2\F6Q(O]/&B>A2M8S$TQE.U^BEJD(N=<PW;5
M'IR&NZ993Y0V,M#0D-0':XK;8"N1Z/D$G*#&5OT(,7$I-X@PK9$GJ\X4D@#O
M$5O&MJ@)/=S4%'L$F%.!O87&7H'=S+/3&TY+XW.7^E"3?.:C:'SI7*3G0++Q
M.81@N[EILR]U<R7\FG[?BRZBV($;N@HYVK$\ FJ5&5:DYHLRV(U/PLM<;ZD5
MH^T<*()>YJ)4<0$4"@O&P$Z4*$H,-"ZD\_P1H"NQ/MR1V*T"HPZC3II%F&40
M"G;>IME#L\-?/B0[_.YX=H?,M*LP6-H=<714D)$!%XJ2B'($V+?F)>W6[+3Z
M@?+]Q030B\5,H=?8QZOM!!:GXM$;B^ 2B$EZB39CP ?68_>+<C:Q9U:NU'>.
MX%'N#N42%W+>ZE36K'Q ]3D%W:I= 9PQ23?5"TH[J!MT".NG9V0;;ZJ)IW@2
MQ"]=:U/O=. "V[]C)@1'0,PX&J(5VP^!E"HE4Q([A#63EUX"OLWGT@H@04CQ
M#-L$-2LK:4;_CK#3/"H.1:&FL\+]S#_@97[(!"N)M8/!RDA,@Y]A'OQTIKT
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M@$Z!"$D[.QX6Z0"H<6N; 4UOMFIM^#M5V)L*&L\&K)^_H/C9'RY!WWYL$7Q
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MS(=!&L[?_N=O3R?%-'[[_P%02P,$%     @  H)M45TC\JT5.@  5%8! !H
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M*B="64_J-QC@LM;^JG[<%C4:NE/O=TX!0E;W2^RGV;)N4?-K@*FH;[N+B9_
MN'JU7P"H+5G_R_-FK=>$+:@U8)5:/:%8N ZVY=G5^?E7V@XPFEO]G@#.;76;
M_:]ED;NV"[8H6M']CJAEC)]Q.PT!QNM%J]?##>6=K)UV?FONU&N7"!OS@H*A
M9&X/^*MLUV#$>J?=K[7:/=&ZN.QT^S5X4*L-MO(%X7Z8U:=:M]%J?Q)?P:@7
MW=:GS_T>S-SZ)"YJ7X'41.WLK%E'=\#I5YP:K,<YW'R.[U)O-G$,O+&E*?"J
M"Z]T"3_^AB_]V19L)1Q>?&D!5<.X,)GF;T!5I[5N%T8_ZW8N:-;-7A_G1:M
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M,D+W@L[^R^X)@R* 5ZL.1N(TE($3\\F,%[D[:MTPVX^#GT,7367K?@JFAVG
MKJLHX<(\Q@ZJD1M/SM3O3N#X<TQOQ.F(]WM[)6!D2F*C1[BJ -(:+OVK]'YY
MZ=W81.EMY0.T54P_HJ(-D.6M0*%.WT?F6S3 5;(-AAW@-T-ORI$7)(,Y#&,B
M77YA$*^C,)*%J+-S9QZ(;EE<CC$?:1J;^ Z./M-?ZTB/TJJ3!;Y\JRN3\K9.
M[M >KC%(.&M^KA+L7K"#P1*89&OF&*N$<S77_"0*Y\F'QBW5)_>;^0&^M(;$
MV+,TB%/*;AFE:Q@]]@7>3^;V=9K&Z&"&-9AAX)#):R[D2AFU4<H27ZS$+-M=
M"CK#\;]A]E6:8+9^Z*>\.GKHL?2G['FPEQQU"UL>QC<.5D60C%D;W/%\UN.\
MW["U"#^6[#5-87&GV4W\CNTIF$>V2@O/02<HQ@-QJ"F0%O$%YX3EDL_481EE
M:\,_:@:EG\RK</CJ5?AX!S\$EB+(>,"),72+8M86. &)&(]!?%_Z?$<87(<X
MNN&"]9,L5W[B3>CDIJ1BU21&!6+L:.ICPF>2KYI06"_,")PJ5R7S;9@=4/(Q
M!<B#4%D<'.-,O-H?+R9FJDP[C+G[W\,],<%EQ8-K9ZX9E0V5R91*C12R@$4K
M@/7TW!0>6 #(]FW$^&33A""RPBG8/(!) .W"%3JZ]1-N5D"[3!'/^*:YJARM
M%E@J ^F'LQ+"[M]581,3/1V%-\X:JI%7 /SR +BYB0"XIDAV28*L*G5@AREO
M "[N!)G#=<]V[MKO@2Y8&:&W%,-B0%8L1 1C%+P3>!,5U*NR;Q=RB ,540"K
MA\.P,'-T;2:6CG84\4!%:Q0D&HR#DTPQFEE:H3H#&2=X]BHC_"-+OR';/\E5
MC7JUNO\STS\W,_^SV;WH+=36NT=-TK44.6301@!AP(3U6090 I:KRGIEV6PZ
M8YY30R(VZA9%KP[FP*IE&<;0Z")78JU$P\3I9.)$'OKF")OH8G'\_=RJ"A"A
MC\^C$E>_I\'0V'DEY4\4_P84Q5'=<!7*&)B/%\EDCH\U<> PG])MM;'T&Z /
M<2!E4"S"I? 2/]*Y<3R?RR]@I L5)_O/*:?5HLT(Y#!O<R]6&-(Q0TOJM:BB
M<IPS1,DU1&7H^IDCHD9'+3EK5Y0)N62@;7)V\NJ)#]ZUE5]2Y'/+C!<5KIH@
MPVX.?=60^SJ#W!/I<'0(%@QD(L3C (\? O^#,'R^,T*'_];!X;9PP;A4QY]4
MRHYJ81A(P^</.J)U25D_)#Y]VEM@*O1&H"/<H> YC!G4<\/Q@,A\^(RY##@5
MF,E<.A'% BD%/?P6A#,@^6M5WX.,#\7X/Y='X>VK1^%C@6$5.[%\TTEYN9ST
MI>0_7;0X%?GS"=PR)!ES/N%MN# C2@S8S%$FD2//)\ND+R&KQ'*8,K=S%/MR
M820P;LR$O_*EUAPQ) +$KT:S2IQDU7!4"AU(FT@.I7<CBY(OMY \"(D3,X0)
M>= V?2E;\ (7KUSV"/W)$WO528>N;M[QPWS!EA 4!2&(!DB,]7O8/^7HM$H&
M#5D)HZ)U]^B,^E)1/[.<QRMTAJHY+S![1LK%5@69MUF)R0GFEB(UXN&GI)(%
M7&,H<'=A-DC<2[TUGU+/E;@QYE)X<V G-CC,'8;%Z"09!3I,9&PP3:&PU=(G
M=9E<-,+AMXDDTAG2J J2Q:4+0M 2%#?J! N:HATFJ-205]A.#.;)6'FG5&Y(
M$B%V8Q%0RHA?/1*=V@3H>&_P2 !S8S&-!(>+K6),=I(M>B1A4?$(G0+%B\G?
M%N#D4P78"2?;(/TXKM@[88VJ:"E7A-CVB#'Y@;+-6'O]<-A]-/<+E#34M?&S
MN.)\&3%B&1*S%#L!-@;M!U&,FXE>%K5:2!)SZ9.@Y1KH-MI>4$#E)YCQZVJR
M$VT]O\F^Q-JM/*.)7N2(EW,,<M\HT:_]VFR+7JM=;W*WNX5^ %]J/:H-WX1+
M&AM@KM>I$@6I ):GB$MTPLH.\  63#"\4E=G!$:KD6T-(B%CI#RJ\4/LB".C
M25:J@6-M(E6)@<] 8FF&5+^8,NAT%'*<+U$JME184.PAHU:.CHZV3XJ%1!<O
M.E"Q^HVH;*J*7JBJHH6KJWM[E37,X_KYJO*]6SN#Z=4M^V1Q6=U$-VRCU6W6
M^]C)H]F^ZC:YQ4^GUFV(;O.LV^Q]?JH#]IXM35XDVI(-V\3C].F1YQL4"@8,
M%N1A2!U162*4Y3) <T#;/)GPQB"A:I5Q.RJ-#--CP@%^K7( 1U@WO%BFAW]R
M]/ 4.CGR@#-E8)Q&IT[,D?HJ7=2XU18KR@YU::S,',@"O=2I]C(C]SJSCPC)
M1O+?J:<BOD Y1>@ZU5-4N36P'Y@YCEIH0M%3IHKN$E,/U@C(>YAR)KHY]L>+
MZ( ,7U5E+J!9%%(-+UK$9(8UO,56I9IYT?K6K-C:R6<\@,'!E*5\T'K>]"A[
MXGH;5$B4.I/CI/DX]8T9'*04'H96])*[]91(JZ-UG:EN5*%4 WF!*%9-/#>+
M[+DJ<HI\C69TXSY?5C(*IYZM'5:%Q] ,/CSDU!%EPU&4=)(Y>W*CF,FI8LI#
M*KF$M(21,#.S]6JLW+V.;2E0\6XV0+ YC0.;%SE3.EB8\VOA<&9#S.IXN-3D
M[ 7C<PBD'.AP8U,4CFQI'9*R;"+%VL53DT%XNU/GSS9D7B3@X4Y#YI$!#V\^
M;CD/[A%Y?\OE&=VOE,0\=CPC?;EBO;&2+0NW;EQ+VO)N4V'!3SQ P4EE<A?(
MH4:.$;30D:C@24.8#%K?2JY1V8\_I#Y>PVP*S>8#]MM(JC:@$A20\QPZ%5-.
MWIRW3/3XXKIZAMV("?2$O %JGNKAE][!*B+W=ES.':N.>'0R FIC@+ESROOJ
M+E978WW%_BC@L95&CUU"-$P3#K94>?@858KWD%#D/(*Y.@]=,0.2&-:(7"$R
M"J<1UEP_N0N1O'+U[5P]V!RNSI,O,Z7J>[84'"U!/BK9,G<$N)1A*!39O=$N
M]%BKTXR!,^7%=UH'%WR HJ(.-5GG?<2HZP(S1=*>BUG+2_'U1IN[[]?.W+V/
MQ4(L=K3"7GD,-5LJB2O9+E5*KI23G+#341A+ M2H)L=*\8_'?EX\3?%8)Y+7
M<(6F96MT&E$U\%O.$X9TX9[)%&M=T9$-BFIL!#+P^/3B@9DD)^(5ASU$8@\W
M0V+7Q#0,*9043Y"G"BT-\83+I?-%W4Y&X1<[[((#(57#R%'^1&X5@=>"'*MP
MLJ+=M@6%\'5$_?F\ (\VLOP8BJK$Z^/5\RUEY)^EQQ9[6G+@C7G%S)PQ=8C8
M(%*H;S8.=?=,51X%\9B*<N?@3PW0=/.6T%B9"(2,%L(S1% U,V-(DU=Z:W_;
MBN&R)F9>13_LOD!Y1!YJ7*K'UA!;XGK**B<_NF! 2X=23 9D6U]3R0..R4W&
M@3?<C4!V4-V9&RR\F]509GK"U+F8S4)QN/?7$B>CF=">9!:*K:HN9AW+I6MI
M.4:PJ@M.()*XN5R%&6EO2@-3VU@Z<68Q["PX5::A#IZ+%P<*K> 'P>7.#8V,
M,O-814(4[>-EOLE7Q/P ^>MNB/RE2#A-&EK?VW1+U<02131&7M[?:#;2+2;,
M8 T-9(=E\4Q>8DYT4^U,54Q%3T_%B7J)XB8U]'R1 ZVGD'FHFKLM>1=3C=L\
M0"L8%?8_T)Y6 O4+9<#O[S[(ZM@I+BZNNJUO[$[-^-O#+!</,ULYW I,-_:S
MW<G1FVXU'*V=U? J(V^7D7(S9&2'<&5>+*)"M7";XM)[2(&%J*Q<_-12NXW&
MTOQ<W1IME[33796QU-/:BK>Y63D[ODFT83$66\FK@YB(9'@0YEQW68U1F:AN
MB;KBB@FF##!Z_VB/0@@7(\SH:?FU4I,:(8[/C,8;!RZ@L+H4UM#7 =/FN6/I
M9WT(<V/!!SX2TM[]W%L.<F[ 8H;3*XQY*(N.-H-%56D+L!&#Q")*9A-U?@G$
M;@C)2F_)"$FW*5WPMJM<;3J<BL66L[T#HHNU:BEWAP'Y ,2E(4ZD>N,'-&%#
M,1IZRH0C[I#VH13"_R2T2JV]$O#C"/AZ0PAX9)GIUCEF3FIGWH&'$2D*U.P(
MG0A&>0ADSDPL%4:.AY$W0)<"#;*<N#E&7(M?.NG&$M*.:K%G/ ^O=/PT.AYO
M!AWWQX5R0KG0%AUW@8J=ST<B.8ID3"W##.'AK^8X?C%>@#R"*A;#!"]SHAG2
M7U ,M\E"$O+<Y*;&\M)1&N1VJYEJ+Y1C30XT?IPN?L>.1YV4X&;FYVV/FT9>
M:+XJ'H9B>7['%[TL"4=<:#!$H1F'Y?N<^CQDLU<<6ZB8JIT7#<9<:5/>$?WU
M8F%M^V7N K[X;_V\]N6T5O]57';.6_6O:Q?L6O>=&?JL\<@&Z_)1=^^ G)@3
M+P91'$;&'L&08;!7  4EOFK3IA*H4-E<ZYYQV0CF=MLA.<8?843[N/W&\5-I
M:L/;_&%2"8"+AC#7'3J\IZ2:.>,R%;T<YS-I%G.I-MHY4=E;.^_$4^3%\U#O
M UH,/V+5EO/SH\\.:NR3HTA+#H74VD,3/,AV%8]C"%UW0\-P^0"/BG;8G3B$
M6V00*U^?X[FK%$.]V<%8MOI91^LZMG$(:&59E$,,\B0^QVPK^-KV31;'S/C;
M7 IH+S5G9V;8( QPHKZG QP6SMWPCR7B0L>*TBRX;O](U>U7J7;T9"SBIIM<
M8(2M#N.<X,LHRPB 0YA.93%@SXNM[<B.W+)X4A4J(;\SI. A*5CS'CM!WHB0
M6^C8. 'T^P[%)$UA@4*7LJND.27G4MM\7*[S")>L=6Z+O%CW.("YV*GV=?0=
MP7>7]"039*;]T$[LF6,@&44PL3"-%4RQ0K#N^=ZY]YV19:SR3U2,E;4&^8G!
M=>RCL:F )T%1J*83*-.&=$^>I$%?0 A1=-,J:6$SO9,FXS#R_LB'T&%6*!<&
MXHK"8+8K;]N39 $%O"UGWW:S$[\*@SN$ ::Z(N^K DS/*P8*++#Y/+E87^+'
M,^7P44QIZ>(_F2TE\$8XQ[S?&1TV&D<?5@P!!@"(K*(HT,%#EBQ6,0W0*KS!
M1&!NQ4Y*87GQ S>< #][P^R$8,LIJHNFFH51&$5!@<R":0) 5+JH2V85B LL
M/DEA*WI9MEPYXI81: ?_9*"\\@K*E[">$?FF73MIF S48-<Y%-L6X6B^4X;=
M0.5O%,F2+;Z<-%--1\;>1-,EO#>\I$?PB=SG\'_D'AF$04K4FR7,&JXM\"O6
MRG<FPJ'  N(!)S'?$H0+N3@*L*;R/9F?XNVRZ"_FP3B+;^/%A4R=@@BB5R29
MZP4W' ))Q:KG8CG3E5:LF@&XF(;EQ=]P/U@7:M6.B\1Z)2]KTBFK2/3$<3I:
M7@:HE5VQC+3\&NR2W,O&47$5TG2$PK^7OQ;UBRZMH8YQ5^L8++%("QJ3VT*Z
MRG%A 8^BNWVXO<13CHI#E:*RT]:RJM>TA(J(5#@6%9-&0K#VF!KT$([B<U'S
MC$ F.AXW#4#-I5' 'G[GNWQDA<<7<[,=K'2SM3OMG>8_FO4K*A-0_UQK=76Q
M/THO73N_VUFNIA>F<1;8 N 'UT-:="RO+'9&\L(1[3#8:?+M-RI-"=%PR%%2
M8RI!YJX<)"N,G,&D%8CBKKHX'%^@Z(Z/4;'<Z+47!-312K?STXVGDF)6E3TO
M%%_!TF1)7>%?(R:LH6!E;ZBR-102@&F<@5Y;/+YB@&Q'\/(D/#D2V1JJ=KA9
M/=2%D]4?S1J'*UF#'<^BTR87=+]5KYU3VO5YY_3T:ZO]233_<=EL-UK]JVZS
M]S0D_R)9U2M?;-%9/$TY=0[#8"X92715IVJ0M_@-'7)QZYEP,)CC?C>_4[?J
MA Z+=$8<WYWUF;"S:C2#Y/S-&;.@H/7EC1;RYJ&^>N#3JGPM*K*76/3*2L76
M+W EB9R0HIVM+HF+%4K48DM[L5$$8@"\QW6@>(U5J+$*?8]#GQK]8N0#2,;0
MI$=E$([RH"(T4TL@UVX\,)RI]!!&1H5#723."G+4U8WCHA="N1/R#_K)3);J
MJ\FRA-YS)('*> I02BXIZ:^:(^*,K$X-)'>&VGBY#K$O=YZVGMMM^1),7UW)
M]!?:HAM0FJTT;W=IG<,AXVJ/D/;^,2P@ %H;C4 E8\%RARPUY;J8. '0#%VA
M4W6*@RS6?MB$U=Q_H@CEI;6!B1&B,<E03L[Q\#S U_'P+R092Z11<SQ1K/FY
M"5MRL')+SI?J)X<JC6*<+# Z=RJZUKD%Q/;4+PJ6,5/R4Y-)MJ!=#.B,[4W%
M=<PJMR@-I%#I&A;8/WT2&GLXCM+8+5MA>X<V'TJM!$H4Q+3TI8DL1^$P57DE
M/P@7K529EHK\S]&0-O6[H8S)Z*242ZH3A"E"L!?2\O)C]I+S;:D0*8+D!*_#
MD2.);8^Q[]&<D#,>8%P[7A G^>,#F ).8!.6]'8U662/;(V,#O3B'RNC3Q[I
M"5@7U;?^V&ZS#:[]G\_@>@D"/7QVN+Q$5OP8O%S:D.9)]8=@.U411SKQG!KS
MQ68]6=5C"RO39,7.3!W,;9/&"[Y1>TU<'=UN9:$H^I:CY:\_U[_FBBM@_ ;J
M0]CL[<W&A,H?G[DJ5=>#Q2)B#>>R5L\<E*X7#[!<%@?@9*XT(W!5E,F9"IUI
MZI0+&ID*0!;[WFP"?%B-R,ZR&"'N-9!A:UZ3A9(P:_F"J_%1+3M0YP H'TN<
MB*$#?(K8FZ-W- 6LH;QIW"IO1BF(&956%#F4QT\I&< <;$LH?&)EQK)H(M4@
MBR8'I4]P=!B9)^Y-.'3@>]6!U%8<VNRT87A9/!'FO<0"-A\BL,,XX=PJ>%V1
M3EUZ19 7W@Z?X?NWAM,;L=.E ;3<V6QA>T[:YT':Q2@G2[HP]ZDP7%70=V+R
MWTP-+ ZOH"8;WB!-..!#R?LME>:)01281#$+N 8I!MHY^4OI8!_F1/)_.^\;
M49E3)3O3'$<A[J&QX=?-%NOG7FPP7Q).N<E)$J$%Z,2$TKB>#:P+&,(3O6I3
M[%@S2@,WQD:<4ZR&8:KB&(5*5V8;Q(AFR=!42L>9JX;B>#B>N6W,>996N$43
M5O41IGJW7/EOT3]R7UR)]M:$ZPD0'>9:,/7OLT(($V;2>FD$#<>BC/]53+X)
M]'*+E@QXO[/V"KB>8##%*CZIT%/(K(3I/Y.W$4P[GRR]53>,,Y@K3J<*=*F0
M+MR&1 :%P:WZ#W#[3V;V'OQ\9N\ST*FNPM'<JFR7,N\H]9]\F!YRW-^=H556
MS2+R36#8U?ZHFAC#_!2892:;:M8M\&H6\!.(;W*^!.IA#*7TI[KQEJI#S_!.
MW\T.=1UCA^GH0U"[JR(93.RTU2 NUS-YF?=\P?@76[)\7=::IY-&5H0$ U*N
M$ -C!BYYRTH((#!F2B%AN!04 +\<]?]*=?;0,I]I?E6*]02E 3&1#*AZ70SR
M$4S-9J_;V(8OO8FQ+4%]4G M]]$S]:CQ)0.9S,+H&Y"F_'<*V%HKD.T"0;ZF
MZM\>&?B"O9N>NP*Z2=_1%H;E.$:28&N!@I:I7-G4&Z:8U$(%'O(M!K!5KG$!
M44V>S+6DR.T^)<A^:!#>VY4&F>E[TFHWFAANAZVKULZ@++I:;;%IU\C; ?D3
MN2#%WKXMOWWW5UVQ<GG3#A.]J:2=%<&IDT3,X0J52] 9([HH%O#[5Y0K5-U
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M377\(<DZ(&&$1"9> ],<D7#WCD[>[^VIOPX.CO1?1WM[*OE(Q]=TO>$W0 E
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M6F8,M9])29^GH&7#$D=IFBQ-CG-?+PT") 4D28I0@FKB^(/%<W'](&#I(7I
MDSVM/J#4(O+[@2Q!X2!1LBAA<2JB0Q%=U89>8KNX*8T?*!/*TR"0&2D9.RA1
M6SZFCGYBZJ%AK[7ZDI5)C%H@-&K@B>5A1P$5.4!OMI(EW @2YT2@8_<2Q2^@
M$K\BJ@85Y!-7@P#WU7_DZUK]1UK:$>1?F\*.*/_B;J8^IA;S2A8@B0.C.7-D
MR1F"1%P*'5E$"1"ADQ,X@,R["?,1W#RHBY[$F])>X*3T7K)T#A-TBB))'0D
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M<L7NR)=P08,S#DN\_V-]58G2,T"RVA/6&_ETC;D9:UR<>_=]G(3%V4?/=5G
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MD%75H:#V'HL#[\&_WF5S3$/?A2%^OKJ\&8_(]<W@9GQ-7AMVUV/[YR^7-Y>
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M              "  0    !D=F$M,C R,#$Q,#8N>'-D4$L! A0#%     @
M H)M49DN%K)( 0  ] (  !0              ( !?0,  &1V82TR,#(P,3$P
M-E]C86PN>&UL4$L! A0#%     @  H)M42>.4$FK 0  1@8  !0
M     ( !]P0  &1V82TR,#(P,3$P-E]D968N>&UL4$L! A0#%     @  H)M
M46]CFI.'"0  (V8  !0              ( !U 8  &1V82TR,#(P,3$P-E]L
M86(N>&UL4$L! A0#%     @  H)M4<N5T.9A!@  D#4  !0
M ( !C1   &1V82TR,#(P,3$P-E]P<F4N>&UL4$L! A0#%     @  H)M43@T
M3F)W5P  WPT" !H              ( !(!<  &5X.3DQ+7-T:7!U;&%T:6]N
M;V9S970N:'1M4$L! A0#%     @  H)M45TC\JT5.@  5%8! !H
M     ( !SVX  &5X.3DR+6YO=&EC96]F<')O<&]S960N:'1M4$L! A0#%
M  @  H)M4?]Z^)/V&P  V:X  !H              ( !'*D  &9O<FUR97-E
H='1L96UE;G1D97)I=F$N:'1M4$L%!@     (  @ '@(  $K%      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
